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Abstract
A survey of gonococcal outer membrane proteins using an expression library 
screened with anti-outer membrane antibody identified sixteen proteins. 
Among them was an 85,000 Dalton (Omp85) protein that was homologous to 
Haemophilus influenzae protective surface protein D15 and the protective 
antigen Oma87 of Pasteiirella multocida. Analogous proteins were present in 
Brucella abortus (Ompl), Helicobacter pylori, and some strains of Escherichia 
coli. These data suggested Omp85 was a member of a family of highly 
conserved proteins which may be important in establishing and /or 
maintaining mucosal infections. This protein was constitutively and 
universally expressed in aU gonococcal strains tested. The genes encoding the 
Omp85 protein from N. gonorrhoeae and Neisseria m eningitidis were cloned 
and sequenced. Both the gonococcal and meningococcal proteins were found 
to possess a typical leader sequence and terminal Phe residue, characteristic of 
outer membrane proteins. The gonococcal protein was 792 amino acids in 
length while the meningococcal protein was 797 amino acids in length. 
Insertional inactivation of the gene in N. gonorrhoeae resulted in a 
merodiploid state, suggesting the essential nature of the gene.
Since inactivation of om p85  appeared not to be possible, an alternative 
approach to study function would be to express Omp85 in a closely related 
species which naturally lacks Omp85, such as Branhamella (Moraxella) 
catarrhalis. Since very little is known about the transformation parameters or 
the genetics of this species, a pilot procedure using N. gonorrhoeae was 
developed. The 16S rDNA locus was used as the target sequence for 
recombintation with a plasmid construct containing the gonococcal promoter 
a n iA  and the bacterial luciferase reporter gene luxA B , inserted within a 
cloned portion of gonococcal 16S sequence. This construct successfully 
recombined into the gonococcal 16S rDNA locus. The transformant, 1400.1, 
emited light in the presence of the substrate n-decyl aldehyde. An integration 
vector for further manipulations of this kind in N. gonorrhoeae was 
constructed.
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I. Introduction
Neisseria gonorrhoeae is the causative agent of gonorrhea. 
Manifestations of this sexually transmitted disease include urethritis in  both 
males and females, cervicitis, and pelvic inflammatory disease (PID) in 
females. Sequelae of these conditions are sterility in both male and female 
patients and ectopic pregnancies. In 1% or less of infected individuals a 
disseminated gonococcal infection (DGI) occurs, leading to a purulent arthritis 
and, infrequently, to endocarditis. An estimated one million new cases occur 
every year. Treatment in the United States for gonococcal infection of the 
fallopian tubes alone is currently at a cost of five billion dollars per year (27). 
Medical concerns of this organism include the rise of antibiotic resistance, the 
high cost of treatment, and the lack of a vaccine to prevent infection. These 
problems are exacerbated by the lack of a suitable animal model, making it 
difficult to identify gonococcal virulence factors.
The gonococcus is a Gram-negative diplococcus. The cell envelope of 
Gram-negative bacteria is a 3-layered structure consisting of a büayered 
membrane, a periplasm containing soluble proteins, a peptidoglycan mesh, 
membrane-linked oligosaccharides, and an outer membrane with proteins 
and lipids of unique structure. Outer membrane proteins of most abundance 
are peptidoglycan-linked Upoproteins with covalent lipid modifications and 
porins, which are oUgomeric B-barrel structures with large aqueous chaimels. 
The lipid bilayer of the outer membrane is asymmetric, with an inner leaflet 
of the same three glycophosphoUpids as the inner membrane and an outer 
leaflet of made of lipopolysaccharide (116). Püi and flagella, if present, 
protrude from the cell surface.
The outer membrane, which is exposed to the environment, carries the
-  1 •
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antigenic determinants of the bacterial surface (109). Certain of the proteins 
and the lipopolysaccharides of the outer membrane function as receptors for 
bacteriophage and colidns (116). The outer membrane provides the cell with a 
passive barrier to substances with molecular weights greater than several 
hundred Daltons. This generally renders Gram-negative bacteria more 
resistant to antibiotics than are Gram-positive organisms, which lack the 
structure (102).
Both outer and inner membranes consist of approximately equal 
proportions of proteins and lipids, but the protein composition of each 
membrane in unique (109). Gel electrophoresis as well as direct purification 
reveal that there are a  few major outer membrane proteins and nearly 50 
additional minor species (109, 126, 133,135,136). Genetic studies have 
elucidated the functions of many of these polypeptides. In general, they confer 
distinct selective advantages on the cell, but few are actually required for 
growth (140, 64, 66, 93, 131). The protein composition of the inner membrane 
is more complex than that of the outer membrane (116), and many of the 
inner membrane polypeptides are enzymes which catalyze essential 
biosynthetic reactions (109). Individually, they constitute less than 0.1% of the 
total cellular protein (109). The inner membrane also contains various 
transport proteins (109).
Lipopolysaccharide is a substance unique to gram-negative bacteria and 
is exclusively located in the outer membrane. When injected into animals, it 
causes endotoxic shock (2). It consists of three components: the outer 
antigenic sugars, the core sugars, and Hpid A (109). The polysaccharide chain 
projects outward into the environment. The sugar residues differ from 
various bacteria and even between strains of bacteria. These are generally
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
referred to as O antigens.
The phospholipid composition of the two membranes is relatively 
similar (109). 60% of the total phospholipid of E. coli is within the outer 
membrane, while the rest is in the inner membrane (109). Phosphatidyl- 
ethanolamine is the predominant component, the remainder consists of 
phosphotidylglycerol and cardiolipin. In general, E. coli and most related 
Gram-negative bacteria do not contain phosphatidyl choline, phosphatidyl 
inositol, sphingolipids, glycolipids, or steroids which are characteristic of 
eukaryotic systems (109). All components of the Gram-negative envelope are 
synthesized on the inner membrane or in the cytoplasm and subsequently 
translocated across the inner membrane and peptidoglycan layer to the outer 
membrane. (109).
One purpose of investigating outer membrane proteins is for the 
potential of vaccine development. Outer membrane proteins are of interest in 
disease control because of their antigenicity. Vaccination with protein 
antigens will usually result in both a cellular (T cell) and humoral (B cell) 
immune response. For protection against bacterial infections, like N. 
gonorrhoeae, bactericidal and opsonic antibodies are of crucial importance, 
while T cells play a more indirect role by regulating the antibody response in 
terms of immimoglobin class sw itch , affinity maturation, and magnitude of 
response (2). T cells are also necessary for the induction of memory and can 
indirectly induce killing of bacteria by activating phagocytes (2).
To better understand the infectious process, we must study the bacterial 
physiology, interaction of the pathogen with host cells, and the immune 
response. Since the immune system responds predominantly to the outer 
surface of a pathogen, a good deal of research has focused on components of
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
the outer membrane, particularly proteins. The recent sequencing of the 
Mycoplasma genetalium genome showed that, of the 482 known genes 
present, one third were devoted to the membrane (53). Many of these gene 
products are undoubtedly involved in synthesis rather than being actual 
components of the cell membrane; nevertheless, a significant portion of a 
bacterial genome appears to be devoted to the construction of the cell 
envelope and membrane proteins. Several sources suggest as many as 50 
outer membrane proteins exist in the Gram-negative cell envelope (110, 126, 
133,135,136). If a third of the genes in mycoplasma are devoted to the 
membrane, then presumably at least that many must be devoted to the 
membrane of gonorrhea, having approximately twice the genomic comple­
ment and having both an inner and outer membrane. To date, only a handful 
of gonococcal outer membrane proteins have been identified (Table 1).
A portion of the proposed research was to identify and characterize 
novel outer membrane proteins of N. gonorrhoeae. Outer membrane 
proteins probably play a significant role in adherence and invasion, and in the 
hosts' humoral and cell mediated immune response to infection. Antigenic 
and phase variation of many gonococcal outer membrane proteins appear to 
allow the organism to escape immune clearing (72, 58,100, 57,148). Therefore, 
identification of outer membrane proteins that do not vary may be useful in 
aiding our understanding of the pathogenesis of this disease and for the 
development of a subunit vaccine.
Known Outer Membrane Proteins of N. gonorrhoeae
Several gonococcal outer membrane proteins have been characterized. 
The following descriptions will briefly summarize what is known about these 
proteins. A complete list is shown in  Table 1.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Table 1: Known Outer Membrane Proteins of Neisseria gonorrhoeae
outer membrane 
gonococcal protein
letter designation approximate 
molecular weigh t
reference
pilin Pil 20kDa 77
porin For 36kDa 73
reduction modifiable R m p 30kDa 167
protein
opacity proteins Opa 30 - 36 kDa 158
tran sfe r^  binding Tbp 95 & 75 kDa 35
proteins
haemin-binding HmB 97 & 44 kDa 90
proteins
lactoferrin binding LbpA 103 kDa 149
protein
iron-regulated protein Frp-B 76 kDa 12
lipid modified protein Lip 23.5 - 28 kDa 67
multiple transferable MtrCDE 44,110,50 kDa 60
resistance CDE
anaerobically induced Pan 1,2,3 54,45,32 kDa 30
proteins
gonococcal parietal lectin GPL 65 kDa 11
glycolipid-binding - 36 kDa 111
adhesin protein
sulfhydryl-containing - 41 kDa 105
protein
penicillin binding PBP-1,2,3 90,63,48 kDa 40
proteins
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The major gonococcal outer membrane protein is porin (For), 
constituting 60% of the outer membrane protein complement (73). The 
monomeric molecular weight of For ranges from 32 to 36 kDa. Trimers of For 
form a hydrophobic channel creating an anion-specific pore (15). For is 
expressed constitutively and does not undergo high-frequency antigenic 
variation in vitro or in vivo (73). A given strain expresses either PorA or 
ForB but never both; these are variants from a single par gene locus (56, 24). 
Antigenic variation exists between strains bu t For is invariant within a strain 
(73). Human convalescent sera had high titers to For (22) and Por-spedfic 
partial immunity was observed in prostitutes recovered from gonococcal 
infection (114).
Intimately associated with For in the outer membrane is reduction 
modifiable protein (Rmp)(96). Rmp was shown to be associated with For in a 
ratio of 3:1 and co-predpitated with For using monoclonal antibodies (nvAbs) 
specific to either For or Rmp (92, 73,148). Judd demonstrated the conserved 
nature of Rmp between strains and the surface exposure of Rmp (71). 
Antibodies to Rmp, although complement fixing, are not bacteriddal and 
block anti-For antibodies from their otherwise bacteriddal effects (119,120). By 
making antibodies to Rmp, the host immune system circumvents its ability 
to quickly dear the organism. Unlike For, whose presence in the outer 
membrane is necessary for survival, null m utants of Rmp are viable (167).
Another component of the outer membrane is the pilus protein (Pil). 
Fill are filamentous processes composed of multiple subunits which function
as adherence ligands. They appear to be necessary for infection, as Fil~ variants
are non-infectious in male urethral challenge (77). Generally, only one 
antigenic type is expressed at a time (65). Expression is controlled at a single
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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locus, pilE (58, 145). Non-reciprocal recombination with a number of silent 
genes, pilS, located throughout the genome, create a wide variety of antigenic 
recombinations (83, 59, 57, 141). The resultant antigenic variation is so diverse 
and recombination is so rapid that an immune response to Pil is unlikely to 
dear the infection. A pilus-based vaccine was tested in Korea but offered only 
partial immunity to homologous strains (18). Pili share a conserved structure 
between strains (58), but unfortunately these regions appear not to be surface 
exposed (125). Work is ongoing in search of conserved surface exposed 
regions of Pil which may generate broad cross-strain immune activity. 
Presumably, immune protection would result from the inhibition of 
attachment to target cells as a result of antibody binding to Pil protein (70).
A third group of outer membrane proteins are designated opadty 
proteins, (Opas), based on their expression in opaque appearing colonies on 
solid media (156). There are at least 11 Opa proteins, a single cell expressing 
from zero to five at any one time (148). Opa expression is regulated by 
translational frameshifting via the preserice of a repeated CTCTT oligo- 
nudeotide within the signal sequence (152). Conserved regions among Opa 
proteins appear to be membrane associated whereas hypervariable regions are 
localized in hydrophilic, surface-exposed regions. There appears to be a 
correlation between expression and establishment of infection (31, 156), 
although cells not expressing Opa proteins have been recovered from infected 
patients during menses and DGI (20,156). There is also a correlation between 
the particular Opas expressed and the cell type infected (85).
Another group of characterized outer membrane proteins are the iron 
regulated protein receptors for transferrin, lactoferrin, and haem. N. 
gonorrhoeae does not secrete siderophores and, since free iron is limited on
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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mucosal surfaces, various specific iron gathering proteins have evolved.
Their expression is regulated by the Fur transcription modulator protein, 
which in turn is regulated by the intracellular iron concentration.
Transferrin binding proteins, Tbpl and Tbp2, acquire iron from human 
transferrin via TonB activation (16, 35). Antibodies against analogous 
meningococcal proteins block transferrin binding in gonococcus amd are 
bactericidal (153). Lactoferrin is thought to have antibacterial properties by 
sequestering iron from pathogens. It is found in FMN granules and on 
mucosal surfaces. Gonococcal lactoferrin binding protein A, LbpA, is also 
regulated by Fur. Clinical isolates may or may not express LbpA, thus it is 
assumed that survival is contingent upon the expression of other iron 
gathering proteins when LbpA is not detectable (149). The haem binding 
proteins are capable of sustaining gonococcal growth when haem is the only 
iron source. It is not known at this time whether this gene is regulated by Fur. 
The molecular weights of these proteins are conserved between all strains 
tested (90). Fe-regulated protein B, FrpB, is capable of taking iron from haem, 
though its specificity and function have not yet been established (12).
Lipid modified protein. Lip, is a broadly conserved yet variable 
molecular weight outer membrane protein. It has been postulated that 
antibodies bound to Lip may interfere sterically with the interaction of 
gonococcal surface constituents and host-cell receptors (67). The recently 
identified multiple transferable Resistance efflux pump, MtrRCDE, is 
homologous to the MexABO proteins of Pseudomonas aeruginosa and the 
AcrAE and EnvCD proteins of Escherichia coli. Mutants of these proteins 
confer a hypersensitivity to hydrophobic agents such as detergent-like fetty 
adds and büe salts (60). Expression of the Pan proteins are induced by
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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anaerobic growth using nitrite as the terminal electron acceptor in the 
respiratory chain. It is thought that within the human host similar anaerobic 
conditions may exist and that these proteins may play a part in survival 
under those conditions (30). The 65-kDa gonococcal parietal lectin (GPL) has a 
lectin-like activity and shares common structural and immunological 
similarities with GroEL in various Gram-negative and Gram-positive bacteria
(II). Glycolipid-binding adhesin protein was found to adhere to various 
ceramide derivatives and may be involved in epithelial cell receptor binding
(III). A sulfhydryl-containing protein was localized to the outer membrane 
by its ability to fluoresce under ultraviolet light (105). Its function is 
unknown. Finally, the penicillin binding proteins, PBP-1,2,3, are thought to 
be involved with membrane synthesis in Gram-negative bacteria and confer 
penicillin resistance (40).
Basic understanding of bacterial physiology, as it relates to the outer 
membrane proteins and their function and role in host cell interaction, 
would increase our understanding of gonococcal pathology in humans. Yet to 
be fully understood are the roles of known and as yet unidentified outer 
membrane proteins involved in gonococcal adherence, invasion, and 
immune evasion. The knowledge gained through understanding of these 
processes may afford insights into the mechanisms of pathogenesis in other 
hum an pathogens.
Mutagenesis and Gene Introduction
One method used to characterize a protein of interest is by insertion of 
a disrupting genetic element into the open reading frame of the encoding 
gene, thereby abrogating expression of the gene product This technique has 
been used extensively in gonococcal research (97,167, 142, 61, 23, 82). To
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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accomplish this, the gene of interest is cloned and an insertional element is 
introduced, either by site directed or transposon mutagenesis. The resultant 
construct is then transformed into gonococcus and recombination with the 
wüd type gene yields a mutant form. One draw back of this approach occurs 
when the gene of interest is essential for growth in the bacteria. In these cases 
either no mutants are obtained or a state of merodiploidy occurs (117). 
Merodiploidy is a state describing the existence of both the wild type and 
m utant forms of the gene in the same cytoplasmic compartment.
Once a gene is disrupted in this manner, complementation with the 
intact gene introduced on a plasmid vector is often used to demonstrate 
restoration of gene function in the organism. This corroborates that the 
original mutant truly contains the disrupted gene of interest and was not an 
artifact unrelated to the intended purpose. In addition, novel genes can be 
effectively incorporated into the gene complement of an organism by 
transformation with a plasmid bearing the gene. Unfortunately in N. 
gonorrhoeae, these latter techniques are either problematic or unavailable.
The latitude of genetic manipulation of Neisserial sp. is limited in 
comparison with Escherichia coli. The isolation of chemically induced 
mutants is difficult (23) and only certain rather large transposons are 
compatible in pathogenic Neisseria (76, 103). Transformation in N. 
gonorrhoeae, however, is easily accomplished due to a natural competence,
limited only by selection of the proper pilus+ phenotype (147). It has been
observed that a 10 bp uptake sequence is necessary for competent cells to take 
up exogenous DNA (46). Upon uptake, DNA is linearized and then re­
circularized once inside the bacterial cell (14). Once inside, homologous 
recombination can occur via the RecA protein (83). Transformation allows
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allelic exchange of disrupted target genes (82) and the generation of hybrid 
mutants (24). Transposon mutagenesis is limited to transposition in cloned 
genes in an E. coli host prior to transformation and gene disruption in N. 
gonorrhoeae (75,142).
Plasmids carrying origins of replication other than what are found in 
Neisserial species do not replicate in N. gonorrhoeae. Stein has constructed a 
shuttle vector for gonococcal transformation (151), however this plasmid does 
not seem to function consistently (54, personal communication, Stuart Hill). 
Although phage transduction has not been observed for N. gonorrhoeae, 
conjugative plasmids have been isolated which facilitate genetic exchange 
between Neisserial sp. (121,122,123). In addition to a small, ubiquitous 4.2 kbp 
cryptic plasmid (84), antibiotic resistance is usually encoded on additional 
plasmids (124). Several small plasmids encoding resistance to ampidllin have 
been described which, although not by themselves mobile, can be transferred 
with the help of certain large conjugative plasmids (121). One of these large 
plasmids carrying the tetM  marker has been described for N. gonorrhoeae 
(80). This plasmid, termed ptetM25.2, can be efficiently mobilized into non- 
competent gonococcal strains (129). Techniques have been refined, using a 
three step process, to introduce novel genes into a host cell without recourse 
to homologous recombination in the final recipient. The gene of interest is 
ligated into an E. coli vector containing part of the tetM  gene. This construct is 
then transformed into the gonococcal recipient strain N214 where it 
recombines homologously with the resident pTetM252 plasmid carrying the 
entire tetM gene. This same N214 strain also carries a conjugative plasmid 
such that mating with a non-competent strain results in the transfer of 
pTetM25.2 which now carries the gene of interest. This plasmid remains in
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circular form and does not recombine with the new host genomic DNA. 
Meyer has constructed a fleet of 'Hermes' £. coli vectors to facilitate these 
manipulations (86).
Another method of introducing novel genes into a genome was 
engineered by Clark (143). This system involves homologous recombination 
witli an intergenic region of the proline biosynthesis operon. The Clark 
proAB vector has been successfully used as a reporter system to assay Pan (68) 
and ompS (48) promoter behavior by measuring B-galactosidase activity 
under various growth conditions. One advantage of this system is that it does 
not inactivate any of the proline operon genes.
Several problems exist with the aforementioned systems of gene 
réintroduction. The pTetM conji^ation system is cumbersome and 
technically difficult. The Clark system uses the proline A and B intergenic 
region as a target site which, unfortunately, exists only at a single locus in the 
genome. This makes homologous recombination an inefficient proposition.
An alternative method of novel gene introduction into N. 
gonorrhoeae involving recombination with either one or more of the four 
16S rDNA loci was exploited. The luciferase reporter gene, luxAB, was used 
together with the gonococcal aniA  promoter. Due to the light-emitting 
phenotype of gonococcal transformants, it may be possible to monitor bacteria 
which contained the gene in situ in cell culture systems (33). This same 
technique may be effective in organ explant models. The luciferase reporter 
system has been successfully used in following Salmonella infection in mice 
(33) and in assaying promoter activity of virulence factor genes in Yersinia 
(112).
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2. Hypotheses:
The first hypothesis to be tested is that there are several outer 
membrane proteins of N. gonorrhoeae which have not yet been identified. 
Specific goals to this hypothesis:
1. Identify a unique outer membrane protein of N. gonorrhoeae
strain FA19.
2. Clone and sequence the encoding gene.
3. Generate null m utants by recombination with insertionally
inactivated genes.
4. Assay adherence characteristics of N. gonorrhoeae IVfôll with
Omp85-specific antibody in cell culture.
The second hypothesis to be tested is that a proposed 165 rDNA-aniA- 
luxAB  construct can be successfully recombined into N. gonorrhoeae and 
that this system can be used to assay promoter activity in vivo.
Specific goals of second hypothesis:
1. Engineer a reporter gene construct containing the promoterless
luxAB  gene w ith a cat selection marker ligated into the 
gonococcal 165 rDNA gene.
2. Ligate the aniA prom oter upstream of the promoterless luxAB  gene
cassette.
3. Transform this construct into N. gonorrhoeae M511 and select
recombinants that are chloramphenicol resistant and ludferase+.
4. Assay promoter for activity under various growth conditions by
measuring luciferase activity.
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3. Materials and Reagents 
Bacteria and Transfoimation
N. gonorrhoeae M Sll (generous gift of Dr. John Swanson) pilus+ cells 
were selected for transformation by visual inspection as described (147). 
Transformation was done by established procedure (147). Selection and 
growth on solid media was done on clear typing media (157) using 10 ng/ml 
chloramphenicol at 37oC, 100% humidity, 5% CO2 DH5a £. coli (Gibco, BRL - 
Gaithersburg, MD) cells were used for all genetic manipulations using 
standard recombinant techniques (8). £. coli XLl-Blue and SOLR (Stratagene, 
Lajolla, CA) cells were used in the generation of genomic libraries as provided 
by manufacturer. Luria-Bertani medium (LB) (8) was used for all E. coli and 
Enterobacteriaceae broth and agar plate culturing. Branhamella (Moraxella) 
catarrhalis (ATCC# 8193) and all meningococcal and gonococcal strains were 
grown on clear gonococcal typing media (157).
Genetic Manipulations and Reagents
Restriction endonucleases, Klenow fragment, and T4 DNA ligase were 
obtained from New England BioLabs (NEB, Beverly, MA) and used according 
to manufacture protocols. Cloning vectors used were pBluescript+
(Stratagene), and pUPl (46). Plasmids were isolated using the QIAprep quick 
spin kit (Qiagen, Chatsworth, CA) and DNA fragments were purified from 
agarose gels using Gene Clean II glass milk (BiolOl, La Jolla, CA). izsi was 
purchased from New England Nuclear (Boston, MA). Sulfo-NHS-LC-biotin 
was purchased from Pierce (Rockford, IL). Enhanced cheimluminescence 
(ECL) reagents were purchased from Amersham (Arlington Heights, IL) and 
used according to manufacture directions. Immunoblotting was done with 
Mülipore (Bedford, MA) Immobilon polyvinylidene difluoride (PVDF). Goat
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anti-rabbit horse radish peroxidase corrugate antibody was purchased from 
Sigma (St. Louis, MO), streptavidin-peroxidase conjugate was purchased from 
Amersham, and protein A horse radish peroxidase conjugate antibody was 
purchased from Boehringer Mannheim (Indianapolis, IN). All other 
chemicals and reagents were obtained from Sigma.
Southern Blot Analysis
Chromosomal DNA, obtained by phenol extraction (8), and plasmid 
DNA, obtained by QIAprep columns (Qiagen), were digested with various 
endonucleases according to procedures of the manufacturer (NEB). Digested 
DNAs were electrophoretically separated on a 1% agarose gel and the DNAs 
transferred to nitrocellulose with the Bio-Rad Model 785 Vacuum Blotter 
(Bio-Rad Laboratories, Hercules, CA) according to instructions and Southern 
(146). Probe DNA was extracted from agarose gels using glassmilk (Vista, CA) 
and labeled with ECL universal primer system (Amersham). Blots were 
visualized using Luminol and autoradiographed on Hyperfilm-MP 
(Amersham).
SDS-PAGE and Western Blotting
Cells were harvested from confluently grown plate cultures after 16 hr 
of growth. These were solubilized in solubüizing buffer, 100°C for 10 min, and 
separated in the discontinuous sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) system described by Laemmli (87). Protocols for 
whole cell lysates have been previously described by Judd (71). Separated 
proteins were either stained with Coomassie Brilliant Blue R or electrophor­
etically transferred onto PVDF as previously described (163). Blotting was 
performed in degassed 20mM sodium phosphate buffer, pH 8.0 for 2 h r at 600 
mA. PVDF blots were blocked in 0.05% Tween-20 in Dulbecco's phosphate
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buffered saline (dPBS) with 3% skim milk for 1 hr at room temperature. 
Primary polyclonal rabbit antibody was added at 1:1000 dilution and allowed 
to adsorb overnight at 4°C with gentle rocking. Rabbit antibody was pre­
absorbed with £. coli lysate for 2 hr at 4oC with gentle agitation. Primary 
human antibody from patients with DGI or meningococcemia were diluted 
1:100. Secondary antibody was either protein A-horse radish peroxidase 
(Sigma), goat anti-rabbit horse radish peroxidase (Sigma), or anti-human IgG 
horse radish peroxidase conjugates (Zymed, South San Francisco, CA). Blots 
were developed with 4-chloro-l-naphthol and H2Q2.
Generation of Polyclonal Antisera
New Zealand white rabbits were injected with a series of four intra­
venous aqueous preparations of outer membrane proteins of approximately 
100 pg total protein per ii^ection. Serum was collected from rabbits before 
initial injection as a negative control. Initial injection used 1 ml Freund's 
complete adjuvant, followed by injections using 1 ml Freund's incomplete 
adjuvant 0.5 ml inoculums were injected subcutaneously at the axillary and 
inguinal sites. Injections were performed every two weeks for at total of four 
injections. Hyperimmune serum was collected intravenously and pooled.
For the generation of Omp85 fusion protein antisera, purified 
pMal/Omp85 was used with 1 ml Freund's complete adjuvant for the initial 
injection. Three subsequent injections with 1 ml Freund's incomplete 
adjuvant was done with cleaved pMal/Omp85 only and Freund's incomplete 
adjuvant.
Fusion Protein Production and Isolation
A 10 ml overnight culture of E. coli DHSa containing the pMal/Omp85
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fusion construct was used to inoculate a l l  volume of LB broth with 50 ^g/m l 
ampidUin. This culture was grown to an ODeoo = 0.4. Isopropyl-B-D-thio- 
galacto-pyranoside (IFfG) was then added to a final concentration of 0.3 mM 
and the culture was incubated for an additional 2 h r at 37oC. The cells were 
then centrifuged at 4,000xg for 30 min. Cells were resuspended in 50 ml lysis 
buffer (10 mM NaaHPOé, 30 mM N aQ , 0.25% Tween 20,10 mM B-ME, 10 mM 
EDTA, 10 mM EGTA) and sonicated for 5 min at maximum strength for 1 
min bursts on ice. Sodium chloride was then added to the lysate to a final 
concentration of 0.5 M and the suspension centrifuged at 12,000xg for 30 min 
to clarify the extract
The clarified extract was batch purified at 4°C with amylose resin (NEB) 
according to manufactures instruction. Briefly, 15 m l of hydrated resin was 
added to ttie extract and gently rocked at room tem perature for 1 hr. The 
crude extract supernatant was removed by centrifugation and the amylose 
was washed w ith three volumes of 0.25% Tween-20 column buffer (10 mM 
NazHPOi, 0.5 M N a d , 1 mM azide, 10 mM B-ME, 1 mM EGTA, pH 7.0) and 
five volumes of column buffer w ithout Tween-20. AU washings were 
performed by gentle resuspension foUowed by centrifugation at 50xg for 5 
min. The peUet was resuspended in 25 ml of column buffer with 10 mM 
maltose added to elute the fusion protein, centrifuged 50xg for 5 min, and the 
supernatant coUected. This process was repeated. The eluate was dialyzed 
overnight at 4oC in distiUed water to remove maltose and then lyophUized. 
The protein concentration was estimated by absorption at 280nm.
The fusion protein was cleaved from maltose binding protein as 
foUows. A 1:100 ratio of factor Xa was added to dialyzed fusion protein in Xa 
buffer (20 mM Tris HCl, 100 mM NaCl, 2 mM C aC h/1 mM azide) and
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incubated at room tem perature overnight. Removal of cleaved maltose 
binding protein was achieved by exposure to amylose resin. The supernatant 
contained the cleaved fusion protein. This was verified by SDS-PAGE. 
lodination
The method used has been previously described by Judd (71). Briefly, 16 
hr cells were harvested and suspended in 4°C dPBS (ODsoo = 1.36). 1.5 ml were 
centrifuged (14,000 x G) for 1 m in and resuspended in 100 pi of cold dPBS. To 
this was added 12SI (4 25 pd/ pi). The entire mixture was then transferred to
a previously iodogenated (l,3,4,6-tetrachloro-3a,6a-diphenylglycouril) 
microfuge tube and incubated a t 4°C for 30 min. The reaction was terminated 
by transferring the cell suspension to a clean tube and washed 3Xs in cold 
dPBS. Radioactivity was assayed using a Beckman 5500B Gamma counter 
(Beckman Instruments, Inc, Palo Alto, CA).
Two Dimensional Gel Electrophoresis
As previously described (106), 16 hr plate cultured cells were suspended 
in cold dPBS (OD600 = 0.68); 1.5 m l were centrifuged (14,000 x G) for 1 min and 
resuspended in 100 pi of first dim ension sample buffer, incubated for 2 hr at 
37°C with periodic mixing, and centrifuged for 2 hr at 100,000 x G in a Beck­
m an airfuge. 10 pi samples were electrophoresed in the first dimension 
using a Bio-Rad Mini-PROTEAN n  2-D Cell and Bio-Rad Bio-Lyte 5 /7  and 
3/10 ampholytes at a 4:1 ratio for 3.5 hr at a constant 750V. Tube gels were 
then run in the second dim ension SDS-PAGE and stained or autoradio­
graphed. Proteins to be N-terminally sequenced were excised from the gels 
and eluted into buffer using a Bio-Rad Model 422 Electro-Eluter as per 
m anufacture instructions. Proteins were concentrated using Centricon spin 
columns (Amicon, Beverly, MA).
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G eneration of FA19 Library and Screening
Gonococcal genomic DNA was partially digested w ith endonuclease 
Tsp 5091. Fragments ranging from 2 to 10 kbp were excised, purified, and 
cloned into Lambda arms predigested with EcoRl provided by the manufac­
turer (Stratagene, Lambda Zap H). The resulting recombinants were packaged 
and transfected onto log phase XLl-Blue host cells. Plaques were transferred to 
PVDF presoaked in lOmM BPTG. Residual E. coli host on PVDF was lysed by 
chloroform and lysozyme before initial incubation w ith antisera. Pre-absorbed 
primary rabbit antibody was applied to PVDF overnight w ith gentle agitation 
at room  temperature. Circles were washed several times w ith dPBS before 
secondary antibody conjugate was applied for one hour. Blots were again 
washed several times in dPBS to remove unbound secondary antibodies. 
Positive plaques were visualized by reaction w ith the chromogen 4-chloro-l- 
naphthol. Positive plaques were identified back to the m aster plate and 
excised from the top agar. Resident plasmids were rescued using helper phage 
as described by the manufacturer (Stratagene). Potential clones were screened 
by western blot analysis (163).
O uter Membrane Preparation
The procedure of Osbom (108) was used and modified by Chuck Tilly 
(34). Briefly, 500 ml of mid-log phase cells were centrifuged at 7,000 rpm  for 
10 min. (8,000 x G) and resuspended in 6.25 ml of 200 mM Tris (pH 8.0) then 
diluted with an equal volume of cold (4oC) 1 M sucrose, 200 mM Tris (pH 8.0) 
solution. To this was sequentially added: 25 nl ice cold 250 mM EDTA, 100 fJ of 
mutanolysin (5 m g/m l in dH20)(ICN Biochemical, Inc.), and 12.5 ml dHzO 
added forcefully by pipetting. The solution was vortexed after each addition. 
This suspension was agitated gently at 4oC overnight. Cells were then
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sonicated using four 20 second bursts at maximum energy output (550 Sonic 
Dismembrator, Fisher Scientific). Unbroken cells were removed by centrifu­
gation at 10,000 rpm  for 10 m inutes (12,000 x G). The supernatant was centri­
fuged again for 30 minutes at 10,000 rpm. The supernatant to this last spin 
was again centrifuged at 55,000 rpm  (240,(XX) x G) for 2 hrs. The pellet was 
resuspended in 1 m l 18% (w / w) sucrose solution.
Sucrose gradients were made using 6 ml of 60% (w /w ), then 5 ml of 55, 
50, 45,35, 25, and 20%, respectively, just prior to use and the 1 ml outer 
membrane suspension applied to the top. After 48 h r of centrifugation at 
24,000 rpm  using a Beckman SW-41 rotor, fractions were removed using a 
peristaltic pum p and fraction collector. Fractions were dialyzed overnight in 
dHzO to remove sucrose. Samples were assayed for total protein content and 
inner and outer membrane fractions pooled and lyophilized. These fractions 
were stored at -20°C until used.
Biotinylation and Avidin (monomeiic)-agarose Capture
As previously described (55), 1 iJ of a 1:20 dilution of sulfo-NHS-LC- 
biotin dissolved in dimethyl sulfoxide (50 m g/m l) was added to 1.5 ml cell 
suspension (ODsoo = 0.68) and incubated on  ice for 1 min. Labeled cells were 
washed 3X in 50 mM Tris-HQ (pH 7.5) to remove unbound biotin.
Once labeled, whole cells were either solubilized in standard SDS- 
PAGE solubilizing buffer and boiled for 10 min or processed for biotin 
capture. Solubilized samples were separated by two dimensional gel electro­
phoresis and blotted onto a PVDF m em brane as previously described (163).
The membrane was blocked for 1 hr a t room  tem perature in TI BS buffer 
(0.01% Tween 20, 20 mM Tris, 137 mM N a d , pH  7.6) containing 3% skim 
milk, washed three times w ith TT'BS, and incubated w ith 10 streptavidin-
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peroxidase coi^'ugate diluted in  50 ml TTBS for 1 hr at room temperature. 
Unbound streptavidin was rem oved by washing in TTBS at 60oC for 15 min, 
followed by two 15 min washes in TTBS at 37°C. All washes were done with 
gentle agitation. Blots were developed by incubation for 1 min in  an equal 
volume mixture of Luminol reagents one and two supplied by the manu­
facture (Amersham). The blot was then autoradiographed w ith hyper-film 
MP (Amersham) for approxim ately 1 min.
For biotin capture, labeled cells were lysed by the addition of 200 of 
2% SDS and 800 nl of PBS. After 1 hr incubation at 37°C, the solution was 
centrifuged to sediment membrane debris and the supernatant was applied to 
an avidin (monomeric)-agarose column (Sigma A-2036) at RT to capture 
biotin labeled proteins. The colum n was washed w ith ten column volumes of 
PBS and captured proteins eluded w ith ten column volumes of O.IM glycine 
(pH 2,0) as per manufacture instruction. The eluate was quickly neutralized 
w ith 2M Tris (pH 9.0) to approximately pH  7 and then de-salted and concen­
trated in a Centricon (Amicon, Beverly, MA) spin column and lyophilized. 
Proteins were solubilized in 2D solubilizing solution and electrophoresed. 
Protein and DNA Sequencing
All N-terminal protein sequencing was done at The University of 
M ontana Molecular Biology Facility (UMMBF) by Joan Strange using an 
Applied Biosystems 473A gas phase protein sequencer. DNA sequencing was 
done using the Sanger dideoxy chain termination method (132) by UMMBF 
using an Applied Biosystems 373A DNA sequencer. DNA sequencing primers 
were either universal or synthesized. Table 2 shows a list of synthesized 
primers. Sequencing strategies are shown in appropriate figures and described 
in the Results section.
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Polymerase Chain Reaction (PCR)
Polymerase chain reactions were performed using a Perkin-Elmer 
Cetus Thermocycler Model 480 and Expand™ High Fidelity PCR System 
(Boehringer Mannheim, Indianapolis, IN). The following conditions were 
used:
cycle 1:2 m in 94°C
cyde 2: (10 sec 94°C, 30 sec 50°C, 2 min 68°C] for ten repetitions 
cyde 3: [10 sec 94°C, 30 sec 50oC, 2 min 68°C - 20 seconds added after 
each successive <yde] for twenty repetitions 
cyde 4:7  min 72°C
PCR products were purified by either Gene Clean II or by using QIAquidc PCR 
purification kit (Qiagen).
Construction of Plasmids
A.pHP45CQ
A PCR prim er to the upstream  portion of the transcription/translation 
term inator elements of pHP45Q (115) was synthesized with an Sp/il site 
induded at its 5' end and ligated to itself (see Figure 25). The resulting 
plasmid, now without the spectinom ydn resistance cassette, was termed 
pHP45. The chloramphenicol resistance gene cassette {ca m) from TnMaxI (61) 
was PCR amplified using primers cat-5' and cat-3', both of which contain an 
S p h l  site (see Table 2 for prim er sequences). This cam cassette was inserted 
into pHP45 in the S p h l  site to create pHP45CQ. Figure 25 shows a schematic 
of these manipulations. Sm al was used to remove the Omega fragment for 
use in the various constructs described below.
B. pDR4 subdones
pDR4 was subdoned using H in d i  restriction endonudease into 
pBluescript. The resulting dones were designated pDR4L, pDR4.2.1, and
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Table 2. List of PCR primers:
1. GC-D15-5'!
2. GC-D15-5'2
3. 4LT7B.1
4. D15-4L-5'
5. D1S-P9
6. D15-4.2.1-5'
7. Nru/33-5'
8. PYFT
9. D15-4.2.1-3'
10. D15 -CT-5'
11. D15-C-T-3' 
12.0mp85CT  
13.5'hypoERVQ
14. OmpHELQ
15. DR4.H.1-3'
16. aniA3'
17. aniAXS'
18. aniAXSM
19. aniA3M 
20 .16SP3'
21. 16SK5'
22. rDNAStuS'
23. rDNAStu3'
24. HLuxAB5'
25. HLuxAB3'
26. Omega
27. 16SBcat5'
28. 16SBcat3'
5' - CCGAATrCATGAAACTGAAACAGATTG - 3'
5' - CCGAATTCCAAGACATCCGTGrC - 3'
5' - CCGGAATTCG ACrrrGACGCGCAGGTAGTrG -3'
5' - TCACGCCCAAAGTAACC - 3'
5' - AGTGTCGATTGAAGGCG - 3'
5' - TTGCCGGTGATGTGGAT - 3'
5' - CGTATCGCAGGACAACCTGTITC - 3'
5' - CCTG AAGTACGG - 3'
5'  -  AGGCATCGACCAGCGTC - 3'
5' - CCGAATTCGAACCCAGGCCGCC - 3'
5' - CGCTGCAGGCAGCGTGTGG - S'
5 '- A AGC TTA GGA CGT CXn* GCC GA - 3' 
5'-GGCGAACGt/c G Tt/c CAA-3' 
S '-TTG C A G Tm TG C A A TTC  -3 '
5'- CCGGAATTCAAACCrrCACGCTGATGCrCGGCG-3'
S' - GGGGATCCnTGTAAGAAAAGTAGGGGGGA - S' 
5'-GGGGATCCGGAATTCCGCCCGCAATGGGACAAC -3 '
S' - GAACrrGGTGTGATrÀTGCGGTrGTCCCATTGCGG - S' 
5' - AATCACACCAAGTTCrTAACrAATCCCCCCTACTT - 3' 
5' - AACTGCAGAGAAAGGAGGTGATCCAGCCGC - 3'
5' - GGGGTACCTGAACATAAG AGTTTGATCCTG - 3'
5' - CCATCGATGAACGGGTGAGTAACATATC - 3'
5' - GGATCGATTGAAGGTCAGTGTTATCCCA - S'
5' - CGGGATCCTACCAACAAATAAGGAAATGITAT - 3'
5' - GGGGTACCCAGCrGiill’lGTlCCTGCAATGAC - 3'
S' - GCATGCGATCCGGTGGATG - 3'
S' - TCATGGCrCAGATrGAACGCTG - 3'
S' - TTCCCCrACGGCrACCrrGTTAC - 3'
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pDR4.H.l. A map of these is shown in Figure 10. Several constructs of these 
three subclones w ere m ade for the purpose of site-directed mutagenesis of 
omp85 by homologous recombination. The Smal Omega fragm ent from 
pHP45Ca was inserted into a unique BsiWl site in pDR4L which had been 
blunt-ended w ith Klenow fragment to create pDR4LCQ. The aphA-3 fragment 
from pSL33 (98) was obtained by Sm al digestion and inserted into a unique 
N r u l  site of pDR4.2.1 to create pDR4.2.1/33 (see Figure 26).
To create constructs w ith larger flanking regions for m ore efficient 
homologous recombination, pOmp85 was created. Primers GC-D15-5'1 and 
OmpH ELQ (Table 2) were used to amplify the entire omp85  ORF plus an 
additional 266 downstreeun base pairs (see Figure 10). This PCR product was 
inserted into the blunt-ended H/ndlH site of pUPl (46) and term ed pOmp85. 
Into the unique blunt-ended Bsi WI site of pOmp85 was inserted the Omega 
cassette, and into the unique N r u l  site, the aphA-3 fragment. The resulting 
constructs were term ed pOmp85CQ and pOmp85/33, respectively.
C  pDRIuxl400.1/pUPl
The luxAB genes (47) from pRL1062 (170) were PCR-ampliHed using 
primers HLux5' and HLux3' w ith B a mHI and Kpnl sites engineered at each 
end, respectively. This product was ligated into pBluescript (Stratagene) 
digested w ith the same restriction enzymes (see Figure 30). The resulting 
plasmid was called pHlux. The PanI (68) promoter, aniA, was constructed 
using the following prim ers: aniA3', aniA3M, aniAXSM, and aniAXS'. Figure 
28 shows the arrangem ent of these primers to one another. Prim ers aniA3M 
and aniASM were allowed to hybridize and Taq polymerase (Boehringer 
Mannheim) was added to fill in the complimentary strands. Primers aniAXS' 
and aniA3' were then added and PCR-amplified to generate the entire aniA
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prom oter sequence (68). Primers aniA3' and aniAXS' were engineered w ith 
BamHî and Xbal sites, respectively. pHlux was digested with the same two 
endonucleases and the aniA  prom oter inserted. This plasmid was termed 
pX.lHlux. The Cû fragment was then ligated into the filled in Eagl site of 
pX.lHlux. The resulting plasmid was term ed pCX lHlux.
The C-terminal 1400 bp of the 16S gonococcal rDNA gene (128, 169), 
traversing base pairs 108 to 1S44, was PCR-amplified w ith primers rDNAStuS' 
and 16SP3' engineered with Clal and Pstl sites, respectively. This product was 
ligated into the corresponding sites of pBluescript (Stratagene) and called 
16S1400. The 16S1400 insert was digested out w ith Clal and Pstl, blunt-ended 
w ith Klenow fragment, and inserted into the Smal site of pUPl (46), resulting 
in the plasmid called 1400 pUPl. A unique A flR  site a t nucleotide 494 within 
the 168 fragment of 1400 pUPl was used to insert the construct of plasmid 
pCX.lHlux. This was done by PCR-amplifying out CX.lHlux using the catS' 
and HLux3' primers and inserting this into the blunt-ended AflK  site of 
1400pUPl. The resultant plasmid was term ed pDRluxl400.1/pUPl (see Figure 
28).
D. pM al/Omp85.
pDR4 was submitted to partial digestion with TspS091 and the resulting 
fragments were ligated randomly into pMAL-c2 fusion protein vector (New 
England Biolabs) digested with EcoRl. Colonies were screened by western 
blotting w ith anti-outer membrane antiserum  and all positive clones were 
analyzed by restriction analysis and sequenced. The chosen clone included 
approximately 100 bp upstream of omp85  ATG codon and 250 bp of omp85 S' 
end.
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In Vivo Ludferase Assay
An in vivo ludferase assay was accomplished as previously described 
(107). Briefly, cells were transferred to ice cold lux buffer (50 mM sodium 
phosphate, 50 mM 2-mercaptoethanol, 0.5% bovine serum albumin, fraction 
V, pH  7.0) to an optical density of 1.0 at 600 ran and kept on ice. Samples of 
100 (J were added to the same volume of substrate and light emission 
immediately measured on a Turner Designs model 20 photometer (Turner 
Designs, Mountain View, CA) for a span of ten seconds. The substrate was 
prepared by a 1:1000 dilution of n-decyl aldehyde (Sigma, D-7384) in ice cold 
lux buffer, briefly sonicated for 2 min before use. The high concentration 
sensitivity setting (lOOOX) was used in conjunction with a synchronized 
remote start switch. The average of three separate assays were used for each 
data po in t
Cell Adherence Assay
The technique of van Putten (163a) was used to assess adherence of N. 
gonoTrhoeae strain M SllLosA (Opa+, Pil-) to Chang epithelial cells in the 
absence or presence of Fab fragments (2a) of Omp85-spedfic antiserum.
Chang human corqunctiva cells (ATCC#CCL 20.2) were grown for 
three days (to confluence) in Dulbecco's Modified Essential Medium (DMEM) 
in 24 well microtiter plates which had 12 mm coverslips in the bottom . N. 
gonorrhoeae MSllLosA O pa+/Pil- were harvested after 15 hr growth to an 
ODsoo = 0.34 in HEPES-buffered saline, pH  7.4. This preparation was then 
diluted 1:50 in HEPES-buffered saline and used immediately in the following 
assay. The medium was removed from the Chang cells and replaced with 1 
ml of DMEM-0.1% IsoVitalex (Becton Dickenson, Cockesvilled, MD). Sterile 
Fab fragments prepared from anti-Omp85 antiserum, anti-bovine serum
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albumin and nonnal rabbit serum were added to a final concentration of 1 
ng/ml, 10 iig/m l and 100 ml to individual wells as was sterile DPBS. Ten 
microliters of gonococci (=2.5 X 105 bacteria), harvested as above, were added 
to each well and the plate gently shaken. The plate was then incubated at 37°C 
for 3 hr in 5% CO2 to allow bacteria to adhere to the Chang cells. Unbound 
bacteria and unbound Fab fragments were then removed by washing each 
well 4X w ith DPBS and the cells and bacteria fixed by adding 1 m l DPBS-2% 
paraformaldehyde to each w ell
Following 16 h r incubation at RT, the paraform aldehyde was removed 
and 1 ml 50 mM Tris-H Q , pH 7.4 was added to each well. The coverslips were 
then placed upside dow n on 100 jJ drops of DPBS-0.5% BSA. This was 
repeated 4X. The coverslips were then placed in 75 4  of a 1:100 dilution of 
anti-gonococcal outer mem brane antiserum, covered and incubated at RT for 
1 hr. The coverslips w ere then washed 3X in 100 jJ drops of DPBS-0.5% BSA 
and then placed in 75 of DPBS-Protein-A-gold (10Â gold)(l:100 dilution of 
commercial preparation - Ted Pella, Redding, CA), covered and incubated at 
RT for 1 hr.
The coverslips w ere then washed 3X in 100 drops of DPBS and twice 
in 100 nl drops of dHzO. The coverslips were returned face-up to the wells of a 
fresh 24 well plate and 1 ml dHzO added. Silver stain was prepared: 2.55 g 
citrate monohydrate and 2.35 g sodium citrate dihydrate was added to 70 ml 
dHzO; 800 mg hydroquinone was dissolved in 15 ml dHzO; 110 mg silver 
acetate was dissolved in 15 ml dHzO in subdued light. The dHzO was 
removed from the wells of the plate and immediately before use, the silver 
stain components were mixed and 1 ml added to each well. The reaction 
proceeded at RT for 10 min, a t which point the silver stain was aspirated and
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replaced w ith 1 ml dHzO. The dHzO was then removed, replaced with 0,004% 
crystal violet in dHzO and the plates incubated at RT for 16 hr.
Adherent bacteria were counted by placing coverslips upside dow n on a 
microscope slide and observed under oü immersion (1,000X). A dherent 
bacteria, which stain black, were counted on 22 cells. The high and low counts 
were discarded and the remaining 20 counts averaged.
4. Results 
Omp85
Figure 1 shows the total protein complement of N. gonorrhoeae strain 
FA19 separated by two dimensional gel electrophoresis. The left panel is 
stained w ith Coomassie Brilliant Blue (CBB). The right panel is an autoradio­
graph of the same strain whose outer membrane proteins were labeled w ith 
1251, There are approximately 12 protein dots visible, ranging in molecular 
w eight from approximately 100 kDa to 14 kDa, each corresponding to a puta­
tive outer membrane protein. Upon overexposure, this same gel reveals 
several additional protein dots, as shown in the left panel of Figure 2. A 
schematic map of this gel is given in Figure 3. Forty one protein dots could be 
detected on the autoradiograph, w ith many more faint protein dots observed 
but not recorded. An arbitrary numbering system was used for catalog 
purposes. Several precautions were taken to minimize the possibility of 
labeling internal proteins via iodine leakage through the membrane 
including decreased tem perature (4°C), limited reaction time (30 min), 
imm obilization of iodagen on wall of reaction vessel, and stabilization of the 
gonococcal cell wall w ith cations (31). For protein, which is approximately 35 
kDa in molecular mass, often smears in the first dimension. A horizontal 
line was used to depict this on the various schematic maps where there was
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Figure 1. Total protein and surface-iodinated outer membrane proteins of N. 
gonorrhoeae FA19 separated by two dimensional gel electrophoresis. 
Isoelectric focusing was used to separate solubilized proteins by charge. The 
horizontal pH gradient ranged between pH  3 to 10 from left to right. Proteins 
were separated in the second vertical dimension by molecular weight using 
standard SDS-PAGE techniques. M olecular weight standards are depicted in 
thousands of Daltons (kD) betw een the two panels. The left panel is a total 
protein separation stained w ith Coomassie Brilliant Blue (CBB). The right 
panel is an autoradiograph (AR) of a similar gel w ith the outer membrane 
proteins labeled with i25i.
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Figure 2. Outer membrane proteins identified by iodination and western 
blotting. The left panels shows an autoradiograph of total protein from N. 
gonorrhoeae FA19 labeled with i25i and separated by two dimensional gel 
electrophoresis. The blot was purposely overexposed to reveal proteins with 
weaker signals. The right panel shows the sanie proteins labeled with 
antibodies generated against an outer membrane fraction from gonococcal 
strain FA19 and visualized by standard western blot techniques (163). The 
horizontal pH gradient runs from left to right w ith a pH range of 3 to 10, and 
the second vertical dimension using SDS-PAGE techniques runs from top to 
bottom. Molecular weight markers are indicated in the center in thousands of 
Daltons (kDa).
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Radioiodination of FA19
Figure 3. Schematic map of radioiodinated outer membrane proteins of N. 
gonorrhoeae FA19 taken from  Figures 1 and 2. Shown here is a depiction of 
these labeled proteins (o). Numbers are arbitrary given for catalog purposes 
and have no intrinsic meaning. Molecular weight markers are indicated on 
left axis in thousands of Daltons (kDa). Horizontal pH gradient extends from 
left to right, rang ii^  from pH  3 to 10. A indicates those proteins also identified 
on western blot and biotinylation.
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smearing. For was arbitrarily assigned the number '20'.
A second method used to label outer membrane proteins was by 
western blotting using antibodies generated against the FA19 outer mem­
brane fraction (108,34). A two dimensional western blot (163) of FA19 is 
shown in Figure 2, juxtaposed to an  overexposed 125% labeled gel, also of FA19. 
Figure 4 is a schematic m ap of this western blot to locate the various protein 
dots relative to each type of labeling system. The numbers used were consis­
tent between the labeling systems. Approximately 47 dots were observed in 
this two dimensional w estern blot. Twenty of the 47 protein dots corre­
sponded to those seen using 1251 labeling. These are indicated by A.
Biotin labeling w as a third method used to identify outer membrane 
proteins using the procedure by Gharbia (55). Biotin is a 244-dalton vitamin 
that can be conjugated to many proteins via primary amine groups. Biotin 
also binds w ith high affinity to avidin and streptavidin. The product used was 
Sulfo-NHS-LC-Biotin (Pierce), a water-soluble derivative of biotin. A 
streptavidin-peroxidase conjugate was used as a secondary molecule to 
illuminate biotin labeled proteins in  the presence of Luminol (Amersham) 
and recorded by autoradiography. The left panel of Figure 5 shows a two 
dimensional separation of proteins labeled with biotin and the right panel 
shows those same proteins which were captured on an avidin-agarose bead 
colturm, also separated in  two dimensions. Sixty one protein dots can 
be seen in  the left panel and eight proteins are seen in the capture b lo t All 
those proteins captured w ith avidin-agarose were also seen in the biotin 
labeling blot. These w ere schematically drawn in Figures 6 & 7, respectively. A 
composite of proteins common to aU three forms of labeling is shown in 
Figure 8.
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Figure 4. Schematic map of two dimensional western blot of N. gonorrhoeae 
strain FA19 using antibody generated against FA19 outer membrane fraction. 
Shown are locations of antibody-labeled proteins from the right panel of 
Figure 3 (o). A indicates those proteins also identified by iodination and 
biotinylation. Figures 1 and 5, respectively. Molecular weight markers 
indicated on the left axis are in thousands of Daltons (kDa). Horizontal pH 
gradient extends from left to right ranging from pH 3 to 10.
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Figure 5. Biotin-labeled proteins from  N. gonorrhoeae FA19 separated by two 
dimensional gel electrophoresis. Left panel shows an autoradiograph of 
approximately 60 proteins labeled w ith sulfo-NHS-LC-biotin. The horizontal 
pH gradient extends on both panels from left to right with a pH  range of 3 to 
10. The second dimension runs from top to bottom  with molecular weight 
maiicers indicated in the center in thousands of Daltons (kDa). The right 
panel shows biotin- labeled proteins captured by streptavidin-agarose and 
separated in two dimensions.
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Biotinytated FA 19
Figure 6. Schematic m ap of biotin-labeled outer membrane proteins from  N. 
gonorrhoeae strain FA19 separated by two dimensional gel electrophoresis. 
Shown are the locations of biotin-labeled proteins from the left panel of 
Figure 5 (o). A indicates those proteins also identified on w estern blots and 
iodination. Figures 1 and 3, respectively, t  indicates proteins unique to 
biotinylation and not found in either western or iodination gels. Molecular 
weight markers indicated on left axis are in thousands of Daltons (kDa). 
Horizontal pH  gradient extends from left to right ranging from pH 3 to 10.
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Figure 7. Schematic m ap of biotin-labeled outer mem brane proteins from N. 
gonorrhoeae FA19 captured w ith streptavidin-agarose. Shown are the 
locations of labeled proteins from the right panel of Figure 5. Molecular 
weight markers indicated on left axis are in thousands of Daltons (kDa). 
Horizontal pH gradient extends from left to right ranging from pH  3 to 10.
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Figure 8. Schematic composite m ap of outer membrane proteins from N. 
gonorrhoeae FA19 labeled by all three methods of surface protein 
identification. Shown are the locations of outer membrane proteins found in 
all three labeling systems separated by two dimensional gel electrophoresis 
culled from Figures 1, 2, and 5. M olecular weight markers indicated on the 
left axis are in thousands of Daltons (kDa). Horizontal pH gradient extends 
from left to right ranging from pH 3 to 10.
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Several attem pts were made to N-terminally sequence gel purified 
proteins identified as outer membrane proteins by these methods. Either 
whole proteins or protein fragments were sequenced. Fragments were 
generated either by chemical (32) or enzymatic (43) means and separated 
either by SDS-PAGE (87) or high performance liquid chromatography (43). 
None of these approaches yielded significant sequence data, presumably for 
lack of sufficient material an d /o r N-terminal blockage from oxidation.
A Lambda Zap n  (Stratagene) library of N. gonorrhoeae FA19 was then 
prepared and screened w ith rabbit anti-outer membrane antibody. Several 
immunoreactive clones ranging in insert product size from approximately 10 
kDa to 100 kDa were isolated. Among these, sixteen clones were partially 
sequenced and a putative identity established by BLAST search (3). Table 3 is a 
list of these clones together w ith their identifications.
Of these proteins, the D15 surface protective antigen protein of H. 
influenzae (50), from done pDR4, was of great interest because of its similar­
ity to outer membrane proteins of four other known bacterial pathogens and 
because antisera to homologs were protective. These were £. coli (17),
Brucella abortus (10), Pasteurella multocida (130), and Helicobacter pylori 
(162). Flack and Thomas discovered that antibodies against the D15 protein in 
Haemophilus influenzae were protective in a rat pup model (159, 49).
Further, human convalescent sera to H. influenzae was cross reactive to D15 
in a wide range of strains tested, making it an attractive candidate for a vac­
cine component (91). Similarly, specific antibodies to Oma87 of P. multocida 
were shown to be protective in homologous challenge in  a mouse model 
(130). None of the other dones listed in Table 3 were analyzed further and 
will not be discussed.
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Table 3. FA19 Library Clones Identified By O uter Membrane Antiserum
Clones Significant Homology
pDR4: Haemophilus surface protective antigen D15
pDRl.18; phosphom annom utase
pDRSL: translocase for m ultidrug resistance
pDR17: GroEL/chaperonin
pDRl.2: RNA polym erase
pDR3.13/ : gonococcal cryptic plasm id protein
pDR3.14
pDR3.24: carbon starvation protein
pDR22.E.l: Listeria invasin protein
pDR27: lipoprotein carrier
pDR3.17/: inosine-5'-m onophosphate dehydrogenase
pDR62, pD Rll, pDR7
pDRl.15 secA translocase
pDR8: Salmonella "virulence factor"
pDR1.19/: catalase
pDR2.12, pDRl.5, pDR3.23
pDR2.5
pDR3.7
pDR3.3
dihydrolipoam ide dehydrogenase
leukotoxin
unknow n protein
Putative MW 
analog 87.5kDa 
47.3kDa 
51.4kDa 
57.2kDa 
149.7kDa 
23.9kDa
60.0kDa
14.2kDa
23.1kDa
51.5kDa
%.3kDa
57.3kDa
60.0kDa
Sl.OkDa
52.8kDa
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The full length D15 homolog gonococcal gene was not present in the 
original pDR4 clone, lacking the final 100 base pairs. Using a downstream 
prim er generated from a contig recently sequenced in the ongoing gonococcal 
genome sequencing project (41), the full length open reading frame was 
obtained and cloned into the Sm al site of pU Pl (46). The resulting plasmid 
was termed pOmp85. All PCR primers used and their respective sequences are 
listed in Table 2. Although pU Pl is a high copy number plasmid, it does not 
contain a high efficiency E. coli promoter contiguous w ith the multiple 
cloning site. This allowed suitably moderate expression of the gene.
The entire gene was sequenced (GenBank accession number U81959) 
and found to contain a typical signal sequence and a consensus terminal 
phenylalanine residue, indicative of bacterial outer membrane proteins (164, 
165, 154). The entire gene encodes a polypeptide having a predicted molecular 
weight of 87.8 kDa. Removal of this signal peptide yields a mature polypep­
tide molecular weight of 85.8 kDa. The gene was nam ed omp85  because of its 
outer membrane location and its apparent molecular w eight of approximately 
85 kDa. The gonococcal protein expressed by pOmp85 was designated Omp85. 
The entire gene sequence is given in Figure 9. A ribosome-binding site 
sequence preceded the initiation codon of the ORF by seven nucleotides. 
Potential promoter sequences were not readily apparent. A putative signal 
sequence cleavage site was identified by the (-3,-l)-rule between the 20 and 
21st amino add (165). The sequencing strategy involved both the subcloning 
o( H ind i fragments into pBluescript and use of the T3 and T7 promoter 
sequences on the vector, and synthesized prim ers for those sequences not 
covered by the available subclones. This strategy is outlined in Figure 10. The 
entire ORF was sequenced a t least twice and m ost of the DNA was sequenced
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Figure 9. DNA and amino add  sequence of Omp85. There are 2376 base pairs 
in the open reading frame of omp85. The protein consists of 792 amino adds, 
ending in a phenylalanine residue, similar to D15 and consistent with 
bacterial outer membrane protein C-termini (154). There is one stop codon 
(TAA; bp 2379) followed by an underlined rho-independent termination loop. 
The putative ribsome binding site (RBS) is shown 7 bp upstream of the 
omp85  ATG start codon. A putative second stop codon (TAG) and rho- 
independent term ination loop (underlined) is indicated upstream of omp85. 
These are downstream elements of an upstream  yeaL E. coli analog. 
Arrowhead indicates putative signal peptide deavage site (165).
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Figure 10. Sequencing strategy for omp85. pDR4 contained a 2933 base pair 
insert in the pBluescript vector rescued from the Lambda Zap II library phage 
clone. The first 291 base pairs included the 3' end of the yaeL gene (17) and the 
ribosome binding site for omp85. The omp85 open reading frame extends 
from base pair 292 - 2667. pDR4L, pDR4.2.1, and pDR4.H.l were subclones of 
pDR4 generated from HzncII digestions ligated into the H ind i site of 
pBluescript. Sequencing of these subclones was done from the T7 and T3 
prom oter sequences found on pBluescript Arrows indicate direction and 
approximate extent of sequence per run. Bottom line shows names and 
directions of synthetic prim ers used to sequence those sections of the insert 
not covered by cloned subfragments.
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from both strands.
Southern blot analysis of genomic DNA from strain  FA19 indicated the 
presence of the gene as a single copy. Figure 11 showed a single reactive band 
corresponding to each genomic digest using four different restriction 
enzymes. In addition, Clal digests of four different strains of N. meningitidis 
also showed a single reactive band to the probe, indicating a single copy of the 
gene in this closely related species. The meningococcal homolog to omp85 
was then cloned from DNA of strain HH (generously donated by Dr. Zell 
McGee) into pU Pl (46) using the same PCR prim ers as w ith pOmp85. The 
resulting clone was term ed pOmp85MC. The sequence is shown in Figure 12. 
It was termed omp85MC  and given the GenBank accession number 
AF021245. The sequencing strategy is depicted in Figure 13. The meningococ­
cal ompSSMC  gene was comprised of 2391 base pairs and encodes a calculated 
797 amino ad d  polypeptide w ith a predicted molecular weight of 88.5 kOa.
The meningococcal Omp85 was 95% identical and 98% similar 
(identical plus conserved residues) to gonococcal Omp85 using the MacVector 
com puter algorithm  (New Haven, CT). The amino ad d  region between 
residues 710 and 730 varied substantially from gonococcal Omp85, induding 
the insertion of five additional am ino adds.
omp85 was also found to be present by Southern blot analysis in all 
other gonococcal strains tested. Figure 14 shows single reactive bands against 
genomic DNA digests w ith Clal, indicating a single copy of the gene in eight 
other gonococcal strains. Figure 15 is another Southern blot of six Neisserial 
commensal strains, four pathogenic and four non-pathogenic Escherichia coli 
strains showing the presence of a single copy of the homolog to the omp85 
gene. The gene was not found, however, in E. coli strain DH5a or in B.
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Figure 11. Southern blot analysis of omp85 in N. gonorrhoeae and N. 
meningitidis. Plasmid pDR4 containing omp85 and chromosomal DNAs 
from E. coli DH5a, N. gonorrhoeae strain FA19, and N. meningitidis strains 
MP3,73, 81, and HH were digested with endonucleases as indicated. pDR4.H.l 
was labeled and hybridized under normal stringency conditions. A single 
hybridizing band is seen in each strain except E. coli DH5a, thus a single copy 
of the omp85 gene is surm ised for each strain. Molecular weight markers are 
indicated on the left in kilo base pairs (kbp).
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S B I S V Q P L P R A E T K T V O F V L H I E P G R K I Y
V B E I B I T G H N K T R 0 B V V R R E 1 . R Q M E S A P Y
GAaCC31XJUUE7roCAM 2XnXXAAASMX:aCGriCaAGCriTroGGCnw:naM 3M3aEK»3tTTaKrGOC(7ICCCGCrRXX
D T S K L Q R S K B R V B L L G Y F D E V Q P O A V P L A
T G L V K S A G V S 0 D H L F G T 0 B 8 A A I . R A S R S C
T T L a G S L B F T D P Y F T A D G V E t O T D V Y G E A
rmQAaZZXKCAAAaamCOAaawaCAKAAACAAIKrAAAKCACCKGOCAOOOOCAOOOKrOCOCATGKOOTGCCiaraCC
F D P R K A S T S I K Q T K T T T A G A G I R M S V P V T
G»ACTCGKrOC(nGA*mra2rTTOQTGQCAGA*383mW 2CTCAK3CCIACA*3UUICCQCCCAAAC*CnVrGCCGAnTT
B Y D R V M F G I . V A E B I . T V H T Y B K A P  K H Y A D F
AiaUKaUMa3RXGCAAAAXGAaaCACAGA3GGCAGCnCKAABaCKaaCTGfMCAA8GGPICCGICG0CTGaGnornrAACAAA
i k k y g k t d g t d g s f c g h l y k g t v g w g r h k
A C a a a G C O COr i 9aGGaxaRaRa3CGGCIAarroAC»g«?IGAAaRrGAAAaCOOCCTOOCCGOCAGCAAA210CAA3acrAC
T D S A L W P T R G Y L T G V H A B I A L P G S E L Q Y Y
YCCOCCACCCACAACCAAA3JlWriX.Vl\.UXTrAAGCAAAAXTlXaCCX7rGA10CiaX3CGGCGAAOICOGCKrrGCGGGCBGC
s a t b h o t h f f p l s k t f t l h l g g e v g i a g g
mCGQC«GAACCTAAGAAA lU .U -T ll .T l^ U AAAACTICnC0GCG0CGGCCrGGU ri a i groCGCaGA3aCGAAAGCGGaCGCTC
Y G R T K B I P F F E H F Y G G G L G S V R G Y B S G T I .
GgrogaAACaGrAJGASGAAIKGGCGAAAAAAJCAGCtACGOCGGCiURaAAAAMCCAAOGlcrcCGCCGRGCTGC ICTl lX U ;
G P B V Y D E Y G E B I S T G G R K E A R V S A E L L F P
M 3Rrn;0CGCGAAiW 3>aXX»Ram7ICCGCCTGM C C T 3m G CCGACaCAGGCACCGrorGGGAC0GCAAA8CCrACGAaaC
k p g a k d a r t v r l s l p a d a g s v h o g k t y d d
AACASCM;riOO3CG«O0QGaRXAGGGTlX::AAAA3ATmCGGCGCCG0CAATNXCKEMjaCCM3CTT7ACCAACGAA3!rGCGC
h s s s a t g g r v q i i y g a g r t b k s t f t i i e l r
Y S A G G A V T H L S P L G P M K F R Y A Y P L K K  
GACGAAAmWUZXTTICCAArrcCAACTCaGCKGAOGriC TAA ' 
D B I Q R F Q F O I . G T T P  
CGGCAM3KrrCGAJRRR»ITITTAa: ATG
K P  E
Figure 12. DNA and amino ad d  sequence of Omp85 MC. There are 2391 base 
pairs in the open reading frame of omp85 MC. The protein consists of 797 
amino adds, ending in a phenylalanine residue, similar to Omp85 and 
consistent w ith bacterial outer membrane protein C-termini (154). There is 
one stop codon (TAA) followed by an underlined rho-independent 
termination loop. The term ination loop is identical to Omp85 except for the 
two intervening base pairs: here is seen two guanosines, while Omp85 
contains two cytosine residues. Arrowhead indicates putative signal peptide 
deavage site (165).
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O m p S S M C
2463 bp
pUPI
AtoflÆcoRl/Oal/HW IIIAXJS/SamHI/Afofl/tSmaO/lCgEBMSmat)
OmpSSMC ORF   OmpH
«>aj8i8giw»B»8«eâ >
Hind]
----------
HHD15CT-5’►
HH 015-52 HH.H.6
HH 015-51 ;T7HH.K8
HHK3T3
HHOmp85<n’ 
M-----------
HH4LT7B.1 HHD154L-5'
U s i
^H3T7rc
HHDR4.2.^-
HHOmpHELQ
HH015CT-3‘
MCMHTSrc IK>
4
-►
S 2 2I ii 01a g
Figure 13. Sequencing strategy of om p85M C . pOmpSSMC constituted a 2463 
bp insert in the pU Pl vector (75) PCR am plified from N. meningitidis strain 
HH (Zell McGee) using primers GC-D15-5'1 and OmpH ELQ (see Table 2). 
HH.H.6 and HH.H.3 were H in d i digestion fragments of pOmp85MC ligated 
into pBluescript vector (Stratagene) and sequenced from the universal 
primers T3 and T7 located on the vector. Anrows indicate direction and 
approximate extent of sequence obtained per sequence reaction. Bottom line 
show names and directions of synthetic prim ers used to sequence those 
sections of the insert not covered by doned subfragments.
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Figure 14. Southern blot analysis of omp85 in eight other gonococcal strains. 
Plasmid pDR4 containing omp85 and  chromosomal DNAs from £. coli DH5a, 
gonococcal FA19, and eight other gonococcal strains were digested with 
endonucleases as indicated. pDR4.H.l was labeled and hybridized at a single 
site under normal stringency conditions in  each of the strains shown except E. 
coli DH5a. Molecular weight m arkers are indicated on the left on küo base 
pairs (kbp).
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■ m i l l ■FA19
I b. catarrhalis
■ N . lactamica
I n. mucosa
I n. cinerea
I n. denltrlflcans
I n. flavescens
| n. animalls
i E. coll W3110
1 E. coll SOLR
1 E. coll XL1
# # E. coll K12
E. coli #43892 
E. coli #35401 
E. coii #43887 
E. coli #35150
Figure 15. Southern blot analysis of omp85 in other Neisserial species and E. 
coli strains. Clal digestion of chromosomal DNAs of strains listed were 
separated in a 1% agarose gel, transferred to nitro cellulose, and probed with 
labeled pDR4.H.l under normal stringency conditions. A single hybridizing 
band appears in all strains shown except B. (Moraxella) catarrhalis. A  single 
copy of eaci omp85-type gene is inferred to be present in all these strains except 
B. (Moraxella) catarrhalis. Molecular weight markers are indicated on the left 
in kilo base pairs (kbp).
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(Moraxella) catarrhalis, thus suggesting it may be non-essential.
The GenBank CDS database was then searched (3) for proteins sim ilar 
to gonococcal Qmp85. Identified were the H. influenzae D15 protective 
surface antigen (49), the P. multocida Oma87 protein (130), the Brucella 
abortus Om pl hypothetical protein (GenBank accession #U51683), the 
Helicobacter pylori D15 homolog (162, GenBank accession #AE000579), and 
an E. coli hypothetical protein (17; GenBank accession # U70214). (And most 
recently Borre/ifl burgdorferi{55\).
The H. influenzae D-15-Ag was 31.5% identical and 61.4% similar to 
gonococcal Omp85. Thomas, et al. (159) dem onstrated that The D15 protein 
was conserved in both typeable and non-typeable strains of H. influenzae 
and reacted with human convalescent sera. They also found that antibodies 
generated against D15 were protective in  the rat pup infection model (161). In 
addition, Loosmore et al (91) showed that H. influenzae serotypes a-f, 
nontypeable H. influenzae andHaemophilus parainfluenzae all expressed 
proteins similar to D15. He also dem onstrated that antibodies to recombinant 
D15 were protective against H. influenzae type a and b bacteremia in the 
infant rat model. The authors claimed that D15 was a universal antigen in H. 
influenzae (91).
The P. multocida OmaS7 was 31.6% identical and 61.3% similar to 
gonococcal Omp85. Oma87 was also found to be highly conserved among 
strains and was recognized by protective antibody. Ruffolo et al (130) dem on­
strated that it was present in all 16 serotypes of P. multocida and was 
recognized by convalescent animal sera. Antibodies raised to recombinant 
Oma87 were also protective against homologous challenge in a mouse model.
The B. abortus Om pl hypothetical protein (10) was 24.3% identical and
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54.2% similar to gonococcal Omp85. A hypothetical E. coli protein was 33% 
identical and 62% sim ilar to Omp85. And an H. pylori putative D15 analog 
(162) was 21.5% identical and 66.5% similar. Characterization of these last 
three proteins has not yet been published and the sequences of the last two are 
from recently completed genome sequencing projects.
A comparison of the seven proteins shown in  Figure 16 using the 
MacVector alignment algorithm  shows conserved regions in  die C-terminal 
region and the final Phe residue. The family Neisseriacae is in the beta 
subdivision of Protobacteria, H. influenzae, P. multocida, and E. coli are all in 
the gamma subdivision of Protobacteria, while B. abortus and ET. pylori are 
in the alpha and epsilon subdivisions, respectively (21). The similarities 
between the proteins seem to correspond to their respective taxonomic 
similarities as organisms. A sim ilar variable region betw een amino adds 710 
and 730 was found between Omp85 and Omp85MC. Figure 17 shows the 
alignment of the conserved 10 amino add C-terminal outer membrane 
consensus sequence term inating w ith a Phe residue. All but E. coli have a 
terminal Phe residue, E. coli having a very similar tryptophan.
A known antigenic region in the C-terminal region of Oma87 
(Manoha, F., Behar, G., Houlgatte, R., HeUman, U., Wroblewski, H., 
Delamarche, C. Direct submission; PIR: S47340) shows considerable homology 
w ith the various Omp85 analogs as shown in Figure 17A. Identical residues 
are in capital letters and sim ilar residues are indicated by a sign. It is 
possible that the C-termini of Omp85 in gonococd and these other organisms 
are also exposed. This portion of the molecules is also quite homologous by 
MacVector alignment (Figure 17B).
Expression of Omp85 was observed in western blot analysis in both one
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Figure 16. Alignment of Omp85 to Omp85 analogs. MacVector alignment 
algorithm was used to determine identities (*) and similarities (.) between 
gonococcal OmpSS amino add  sequences and the amino add  sequences of 
Neisseria meningitidis Omp85MC, Haemophilus influenzae D15 (160), 
Pasteurella multocida Oma87 (130), Escherichia coli (17), Brucella abortus 
O m pl (10), and Helicobacter pylori (162).
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3 .  P . m u lto c id a  
Ckaa87
gVDviykvkE R nT G Sinfgi GygtesGLsy qAsikQ CNfl QnGsSisTqg
**** .*_* ********* *. **** ***.***** * *.* ** *
4 .  E . c o l i
S . B . a b o r tu s  
Onpl
gVDwykvlcB R nT G Sfnfgi G ygtesG vsf gAGVqQCNwl OTGyavging
* * * *  . * , *  * * * * * * * * *  * ,  * * * *  .  * * *  * * *  *  * * *  * , * * . *
t t g
I
g V iL w d w E  k S T G efsig g  GygespGaqv e A a i t e r N f l  G rG gyirisA
** * *_* * * * * *****  *. * ..* ,***** *** * ** *.*
( y a n ia t g  ggrsypgmpk gagrm fagn l s l t n p r i f d s  v iy s s t in ly a  d y r is y q y iq  q g g g fg v n v g  rm lg )
6 .  H. p y l o r i -mDLlvSveE grT G qLqfgl QygaygGünl ngsVSerNLF (TTGqSmaL—  
*** ***_* .** **** *. .**** ****** *** ***** **
N . g o n o rrh o ea e  
Ckq)85
460 470 480 490 SOO
SRSKTTLMGS LSFTDPTFTA DGVSLGYDIY GKAFDPRKAS TSVKQYKTTT
1 . N . m e n in g i t id is  
d u p es MC
SRSKTTLNSS LSFTDPYFTA DGVSLGYDvY GKAFDPRKAS TSiKQYKTTT
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
56
2 .  H. in f lu e n z a e
DIS
3 . P . m u lto c id a
Ckna87
4 .  E . c o l i
5 .  B . a b o r tu s
Ctapl
6 .  H. p y lo r i
N. g o n o rrh o ea e  
Câ>8S
1 . N . m e n in g i t id is
C B ^S MC
2 .  B . in f lu e n z a e
DIS
3 . P . m u lto c id a  
Ckna87
4 .  B . c o l i
5 .  B . a b o r tu s
Q n ç l
6 .  H. p y lo r i
N . g o n o rrh o ea e  
Cknp8S
1 .  N . m e n in g i t id is
Ckq>85 MC
2 .  H. in f lu e n z a e
DIS
3 . P . m u lto c id a
dna87
tkn<fygtsvn  LgyTePÏPTk DGVSLGgnvf fenyDnsK sd TS-snYKrTT
***, . * * ********* ****** *** .,**  .**, ** .*** **
tR n d y g ttv n  LgynePYFTk DGUSLGgnvs feeyD ssK sn  TSa-gYgrTs
***. , , * ***.***** ****** ** .,***,*** **_ * **
tk n c^ q ty a e  LSvTnFYPTv DGTSLGgrlf yndFga—d d  a d lsd Y tn k s
* * * ,  * .  * *  * * * * * * ,  * * * * * *  * *  * . * * *  * . * . * * . .  *
gagqddm m g LSFTePYFlg yrlSaG fD vf r r s y — R  vnd-dYdveq
* * * .,* ,.*  ******** * ** ***** *** * _* * * ,.,
nRtkvsLgyn L n vT k llF ss p ly n ry Y ssv  n ew sP R q cS  T p a s v ü n r l
***..**. * ** *. *** • * »** * **..
510  520 530 540  SSO
AGG6VRMGIP VTEYIBZVMFQ LAAEHLTVMT YNKAPKRYAD FZKQYORTDG
AGaGiRHsvP VTEXDRVBFG LvAEELTVMT YMKAPKhYAD FIKkYGKTDG
********** ********** *,******** ********** **********
yG snVtlG fP VnEnnsyyvG L ^ t y n k is n  fa le y n R -n l yl-QsmKfkG
**.* **** *.* *. * * * . .  .**. * . . * * .  ** * * .*
r
I
yG G nltlG fP V nE -nnsyy- Lgvgy-TyNk IkniapeYnD lyrQsmKynd
p w
I I
yO tdV tlG fP inEY nslraG  L gyvH nslsn mggvamRYly sm gehpsTsd
*.** **** *.***.*. * ** » ***, **,*.** * *, ,*.*
n g
I 1 .
tG G tiRfG lP iT d fsa ia y n  LvgEkydl—  frgdaenY —  y a p a lle a a e
* * * .* * .* * *  ****. * .* .  * . . * .  .* * .  . * . . *  * . . * . .
wd
I
sQ G ktplq-P e s c s s p g a i t  t s p E ir g ir d  Y h t p i t s s f t  IdvsYdnTDd
*** . .*  * * .* . *** .* . .  **.* . .  . * ******
560 570  580 590 600
ADG8FKGLLY KGTVGHGRMK TDSALMPTRG YLTGVNAEIA LPGSKLQYYS
tDGSFKGwLY IR3TVGHGRNK TDSALHPTRG YLTGVNAEXA LPGSKLQYYS
-n G -iK tn d f dfsfGHhyNs InrgyfPTkG v k a a lg g r v t  iPGSdnkYYk
** **. * . * **. *. *.* .**** ***.* ** ****. ***.
s-w tFK ahdf dlsfCSftiyNs InrgyfPTkG v r a n ig g r v t  iPGSdnkYYk
* **** * , * **. *. *.* .**** *.*.* ** ****_ ***_
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4 . E . c o l l qOnSFRtddf tfnyCWtyNK IDrgyfPTdG s r v n l t g k v t  IPGSdneYYk
****. &**.
5 . B .  a b o r tu s  
Ckopl
6 .  H. p y lo r i
n s p w lr s s v -  s y s l t y s - s i  dDikn-PhdG ly g k f i i^ f A  glG gdakZvk
.*** **. **
y y fp m O v if  s s y a t n s g lp  ssgtXi-nswn gLgOrivnitk vyG -K faaY -
* ***** * .* * *  **. * .*  * . * * * * . *
N . gon o rrh o ea e  
CZup85
1 . H. m e n in g i t id is  
QapSS MC
2 .  H. in f lu e n z a e
DIS
610 62 0  630 640 6S0
ATBNQZWFFP LSXTFTUILG GSVGXAGGYG KTKBIPFFBN FYGGGLGSVR
AIBMQIWFFP LSKTFTUILG GEVG1A067G RTKEIPFFBH FYGGGLGSVR
ka
1
IsadvqgFyP L d rd h lw w s asaGyAnGfG -n K rlF F yq t ytaGGlGSIR  
* * *** * * *** * . , *  * .* * *  _* * * * * * , * ********
s a
3 .  P . m u lto c id a  
Ckoa87
InaeaqgFyP LdrehgwvLs 
. * .  *** * .* .  .  ***
s r is fA d S fs  -gK rlP P ygy  ysaGGiGSlR  
* ******** .*  ***** * ********
4 .  B . c o l i
5 .  B . a b o r tu s
CBçl
6 .  H. p y lo r i
v T ld ta ty v P  idddhkw L G  
. * * * * *  * . . .  **
e a
I
tT fk g n y y q t LSqdivglLG  
** * . . *  . * * * .* .  ***
-h H lQ k -y l-  L i - d l i a r f k  
* * .  ** * * _*
rtrG ygdSlG  -gKBmPFyBN PTaGGestVR 
. * *** * .******** ***** ****
vgaG yihefG  -d d g v r iF d -  I f k n s s d ü R  
**  * .* * *  * * , * * * *
tqgG yifrY n t d d y lP ln s t  FïtaQGvttVR 
.*  * * .  . .  *** . .  ** * * * .* * *
N . gon o rrh o ea e  
CSg)8S
1 .  R . m e n in g i t id is  
CB^85 MC
2 .  H. in f lu e n z a e  
DIS
660 670  680 690 700
GÏESGILGPK VYDEYGEKIS YGGMKKAMVS AELLFPMPGA. KDARTVRLSL
GYBSGIL6PK VYDEYGEKIS YGOIKKANVS AELLFPMPGA KDARTVRLSL
fk
I
a  gngn d v i  f v
I I I  I I
GfayGsiGPn lYaEhGtKXS sG O IaittaS  A E L ivPtPsd KsqnTVRtSL
**. ****** **,*,*,*** *** * ..*  **** * **. * ...* * *  **
c l
3 .  P . m u lto c id a  
Ctna87
a  r t r q c p  f v
I II I
GfayGaiGPn iY D sY vssdv iGGNamvtaS tE L ivP tP ad  KixpisVRtSL 
* * . ****** * * * .*  *** . , . . *  **** * * * . * * , ,* * *  **
( fp h  qasnyc^xlyd yeca tq d gak )
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4 .  B . c o l i GfqSnTiGPK V Y D lcksdda vGGNamAvaS lE f i t J P tP s d  KyAnsVRtSf 
* * * * .* * * * *  *** . . .  * *** .*  . *  *** * * * .  * * .♦ * *  **
5 .  B . a b o r tu s  
CBçl
G fkfngiG Py qdaknOoryw m O Q ttyfsg t ABv<ÿFPMPvl p eslgV R gaf
*.* **.. * * •** ****
6 .  H- p y lo r i G fm G evtPK  — DEfG— Iw  IQ G d giftaS  tELsygvUcA akm Rlawfgf
**** * *•* *** * * * . * .****
N. g o n o rrh o ea e  
GDpâS
710 720 73 0  740 750
FADAGSVWDG RTMAAENOf NKSVYSEKAH KSTFTNELRY SAGGAVTHLS 
ddns g
1 . N . m e n in g i t id is  
CbçSS MC
FADAGSVWDG kTY ssA tgG r
* * * * * ♦ ..* .
vgiiY agN tH  KSTPTOBUtY SAGGAVTWLS
2 . H. in f lu e n z a e  
DIS
FvDAaSVWnt k-vdcsdksG l d n n V lk slp d  y g k -s s r iR a  StGvgfqWgS 
* .* * * * * * * . * * * * • ** * .  *♦ ** *** * * *
3 .  P .  m u lto c id a  
Ckna87
FvDAaSVWnt
*.*******.
R-wkAedkak fa k l-n v p d y  -S d -p srv R a  
-* * *. .* **
SAOvAlqwgS 
*** *** *
4 . B . c o l i FWOnGtVWDt -nw  d s s q  y-SgYpd— y  -S d -p sn iR m  SAGiAiqWaS
• * ***»*_ **** * *** *. .**** *** ** ***
S . B . a b o r tu s  
CDpl
FADAatly-G  
* * * * * * * . *
nd-T pdisG d  
. .  **. ***
-dKklRa SvGvsloW aS
* * * * * *
6 . H. p y lo r i I t f k t p t r g s  ffYnJ^jtvtta N fk dY gviga  g fe -r a tw R a  S tG lq ieW iS  
** .* .* * *  * .* *  . . . * . * * *  . . .  * *** .* .* * *
N. g o n o rrh o ea e  
COp85
760 770 780
PLGPMKFXYP YPLKXKPEDE IQRFOFQLGT TF
1 . N m e n in g i t id is  
OnpSS MC
PLGPMRFrYa YPLKKKPEDB IQRFQFQLCT TF
2 . H. in f lu e n z a e  
DIS
PiG PlvFsY a  
* * * * *  *  * *
kPiKXÿenDd 
* * * *  * * *
veqFQFsiGg sF  
* * * * * *  * * .  * *
3 . P . m u lto c id a  
Ckna87
PiG PlvFsY a  
* * * * *  *  * *
kPLKKyqgDB 
* * * *  . . * *
leqPQ FsiG g TF 
* * * * * *  * * .  * *
4 .  E . c o l i PLGPlvFsYa 
* * * * *  *  * *
<ÿ?fKRydgDk 
* * * *  * .
aeqFQFniGk Tw 
* * * * * * * * .  * *
S . B . a b o r tu s  
cnpl
PfGPlrFdYa  
* * * * * * *  * *
fPvaKadtDk  
* * *  *  . * .
vQ nFnFgvst kF 
* * .* * *  *** . *
6 . H. p y lo r i Pm G PlvlIfp  
* * * * *  * * * *
i a f
**
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P. mul.
H. inf.
E. coli.
N. gon.
N. men.
B. abo.
H. pyl.
GVALQWQSPIGPLVFS YAKPLKKYQGDE lEQFQFS IGGTF 
GV QWQSPIGPLVFSYAKP+KKY+ D++EQFQFSIGG+F 
G+ALQW SP+GP+ F YA PLKK DEI++FQF +G TF
G A+ W SP+GP+ F YA PLKK DEI++FQF +G TF
G A+ W SP+GP+ F YA PLKK DEI++FQF +G TF
GV+L W SP GPL F YA P+ K D+++ F F + F
G+ ++W SP+GPLV + GD + F+FS+G F
Figure 17A. Homology to P. multocida Oma87 antigenic C-terminus with 
Omp85 and Omp85 homologs. Identical am ino acids are lettered and similar 
residues are marked w ith +. Organisms listed in order of similarity to OmaS7 
C-terminus of P. multocida using M acVector alignm ent algorithm.
N. gon. I Q R F Q F Q L G T T F
N. men. I Q R F Q F Q L G T T FH. inf. V m g F Q F m g I G S FP. mul. I :=!# F Q F « I G T FE. col. A A#! a # F Q F I G T WB. abo. V 0 m F N F m a V S T g#g FH. pyl. T Q H F E F g#::::m m à  G T gm F
Figure 17B. Alignment of last twelve am ino acid residues of Omp85 using 
MacVector alignment algorithm to Omp85 homologs. Dark stippled area 
shows dissimilarities, all other areas are sim ilar or identical.
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and two dimensions. Figure 18 shows Omp85 expression in £. coli DH5a via 
the pOmp85 plasmid. No expression of the protein was observed in E. coli 
DH5a alone. Adjacent is show n the same cell lysates on SDS-FAGE. In 
addition, Omp85 expression was observed in all other gonococcal strains 
tested as well as in several meningococcal strains (Figure 19). Figure 20 shows 
a two dimensional blot of gonococcal strain Nfôll using antisera from Omp85 
fusion protein, locating the specific position of OmpSS. Figure 21 shows a 
western blot of several gonococcal and meningococcal strains using the same 
fusion antibody to show its specificity. The numbering system of Figures 2, 4, 
and 6, identify Omp85 as protein num ber 46.
If Omp85 were required for mucosal colonization, it was hypothesized 
that commensal mucosal N eisserial species would harbor the gene. Thus 
several Neisserial commensal strains were tested for the expression of 
Omp85. Figure 22 shows the results of this survey. All species tested showed 
evidence of a reactive protein in  the 85 kDa range. The molecular weights of 
these Omp85 analogs varied slightly in molecular weight. Interestingly, B. 
(Moraxella) catarrhalis, a species dem onstrated to be closely related to the 
Neisseria genus by 16S rDNA analysis (127), showed no expression of Omp85. 
To assay the extent of Omp85 expression in the Gram-negative bacteria, a 
western blot was perform ed using whole cell lysates of various pathogenic E. 
co/i strains as well as Sa/moneZ/a typhimurium and Shigella flexneri.As 
shown in Figure 23, all E. coli and Enterobacteriaceae strains failed to react 
w ith the Omp85 antiserum.
This is an interesting result w hen compared with the Southern data 
previously mentioned which show ed the presence of the homolog in all E. 
coli strains tested, w ith the exception of DH5a. These data either suggest that
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Figure 18. Western blot analysis of Omp85. Cell lysates of E. coli DH5a, E. coli 
DH5a with pOmp85 plasmid, and N. gonorrhoeae strain FA19 were separated 
by SDS-PAGE (12.5%)(left panel) blotted to PVDF and probed w ith antibody to 
outer membrane fraction of N. gonorrhoeae FA19 (right panel). Omp85 
position is indicated in the center column. Molecular weight m arkers are in 
thousands of Daltons (k).
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in m «n m
s» s, 8,
- OmpSS
anti-OM antiserum
Figure 19. Western blot of Omp85 in  other gonococcal sp. and in  clinical 
isolates of N. meningitidis. Cell lysates of E. coli, E. coli expressing Omp85, 
and several strains of both N. gonorrhoeae and N. meningitidis were 
separated by SDS-PAGE (12.5%) and blotted onto PVDF. Rabbit antibody to 
outer membrane fractions of N. gonorrhoeae FA19 was used to indicate the 
presence of Omp85 in all strains tested except E. coli DH5a. The position of 
Omp85 is indicated on the right. M olecular weight markers are indicated in 
thousands of Daltons (k).
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Add lEF Basic kDa Add lEF Basic
Figure 20. Two dim ensional western blot of Omp85 in  N. gonorrhoeae strain 
M Sll. Cell lysates of M S ll were prepared as described in  Materials and 
Methods and the proteins separated in two dimensions. The left panel is 
stained w ith Coomassie Brilliant Blue and the right panel is a western blot of 
the same gel probed w ith antibody generated against Omp85 fusion protein. 
Small arrow indicates the location of Omp85. Molecular w eight markers are 
in thousands of Daltons (kDa). Horizontal pH gradient extends from left to 
right in each gel, ranging from pH 3 to 10.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
64
t
t i
o o d d d r
(k) u iu is :  ^  3 :3 :2( 2 : 3 : ^ 3 : 2 :
!
8 g
ii
11
04
-Omp85
anti-Ofnp85 antiserum
Figure 21. Western blot analysis using fusion protein-generated antibody. Cell 
lysates of E. coli DH5a, E. coli DH5a expressing Omp85 and Omp85 MC, and 
various gonococcal and meningococcal strains were separated by SDS-PAGE 
(12.5%) and transferred to PVDF. Rabbit antibody to Omp85 fusion protein 
reacted with Omp85 proteins as indicated on right. Molecular weight markers 
are indicated on either side in thousands of Daltons (k).
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Figure 22. Western blot analysis of Omp85 in Neisserial commensals, B. 
(Moraxella) catarrhalis, and two speàes of the Enterobacteriaceae. Cell lysates 
of E. coli, E. coli expressing Omp85, N. gonorrhoeae FA19, several Neisserial 
commensal species, B. (Moraxella) catarrhalis, Klebsiella pneumoniae, and 
Pseudomonas aeruginosa were separated by SDS-PAGE (12.5%) and 
transferred to PVDF. Omp85 was identified only in Neisserial species by anti­
outer membrane fraction antibody. Its position is shown on the right. 
Molecular weight markers are in thousands of Daltons (kDa).
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Figure 23. Western blot of Omp85 in the Enterobacteriaceae. Cell lysates of £. 
coli DH5a, E. coli DH5a expressing Omp85, N. gonorrhoeae FA19, Salmonella 
typhim urium , Shigella flexneri, E. coli (ATCC# 35150 - cytotoxic strain; 
ATCC# 35401 - enterotoxic strain; ATCC# 43887 strain - mucosal adherence 
strain; ATCC# 43892 strain - enteroinvasive strain), N. meningitidis strain 
HH, and E. coli expressing Omp85 MC were separated by SDS-PAGE (12.5%). 
These were blotted onto PVDF and probed with antibody to outer membrane 
fraction of N. gonorrhoeae FA19. The position of Omp85 is indicated on the 
right. Molecular weight m arkers are in thousands of Daltons (kDa).
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omp85 is not essential in  the Enterobacteriaceae and that expression of 
Omp85 is inhibited, or, m ore likely, the antibodies used did not recognized 
the epitopes of E. coli Qmp85 exposed on the outer surface.
Figure 24 shows Qmp85 to be recognized by antisera from human 
patients w ith meningococcemia and diseminated gonococcal infection by 
western blotting. Naive hum an sera did not react w ith Omp85. These data 
indicate that Omp85 is expressed in vivo and that it is antigenic.
Antibody generated against a pMal/Omp85 fusion protein was used to 
identify the location of Omp85 on a two dimensional gel. Figure 20 shows 
Omp85, indicated by the arrow. The predicted p i of Omp85 is approximately 
8.75. Several two dimensional western blots were made using the fusion 
protein antibody. The position of Omp85 varied somewhat. The pH gradient 
here is not linear, the m ajority of the proteins falling w ithin the 5 to 7 pH 
range.
In order to further characterize the Omp85 protein, attem pts were 
made to insertionally inactivate omp85 by homologous recombination. This 
would allow phenotypic changes to be observed with the absent gene product 
and possible function ascertained. Several constructs of the gene were made 
in E. coli using the Omega cassette and the aphA-3 fragment. The Omega 
fragment consists of a chloramphenicol resistance gene flanked by 
transcription and translational terminators at either end (see Figure 25). 
Insertion of this fragm ent in an open reading frame causes termination of 
transcription and translation of that gene as well as that of any downstream 
genes that might be in an  operon. Should Omp85 be in an operon, the entire 
operon could be disrupted using this form of mutagenesis. Phenotypic 
changes in the organism as a result of gene inactivation may give clues to the
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Figure 24. Western blot of pO m p85/E. coli DH5a, N. gonorrhoeae M Sll LosA, 
and N. meningitidis HH probed w ith human convalescent serum. Whole cell 
lysates were separated in a 12.5% SDS-PAGE gel and either stained with 
Coomassie Brilliant Blue (CBB; panel A) or blotted and probed with normal 
hum an serum (pool of 25 patients w ith no history of gonococcal or 
meningococcal disease (NHS; panel B), serum from a female patient w ith 
disseminated gonococcal infection (DGI; panel C), or serum from a male 
patient (HH) suffering from meningococcemia w ith N. meningitidis strain 
HH. The meningococcus strain H H  was isolated from patient HH whose 
serum was used in this blot. All sera was used at 1:25 dilution. Patient sera 
reacted w ith Omp85 in N. gonorrhoeae and N. meningitidis indicating 
Omp85 was expressed during infection. The sera d id  not react with cloned 
Omp85, either because of topological differences when expressed in E. coli or 
due to antigenic variability of Qmp85 in the infecting strains of gonococci and 
meningococci. Molecular weight m arkers in thousands of Daltons (k).
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Figure 25. Omega and aphA-3 fragment construct. The omega primer was 
used to PCR-amplify the pHF45û plasmid without the streptomycin/ 
spectmomydn resistance gene cassette. The resulting plasmid, termed pHP45, 
still retains the ampicillin resistance gene marker. In the place of the
Spcr/Smrgene was inserted the chloramphenicol resistance gene {cam) from 
TnMaxl which has a gonococcal Opa promoter. The resulting plasmid was 
termed pHP45Co. A Swal digest of pHP45CQ yields the Omega fragment with 
the transcription-translation termination elements flanking either end of the 
ca m cassette. Shown is only one end; the other end is identical but in the 
opposite orientation. The bi-directionality of the Omega fragment abrogates 
the need for screening clones for correct orientation of insertion.
At the core of the aphA-3 fragment lies a promoterless cat cassette. 
Upstream of the cat cassette contains three stop codons in all three possible 
reading frames and downstream of the cassette lies a ribosome binding site 
and an in frame ATG start codon. A S  mal digest of pSL33 yields the blunt- 
ended 650 bp aphA-3 fragment. This fragment must be ligated in frame with 
any ORF and can only function in the orientation shown. Downstream genes 
of a possible operon are allowed to be translated normally with this construct.
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Omega (1.03 kbp) 70
BamHI
SlROl
£cdRI
.BamHISmol
EcoH
Hindlll
Sph\\
cat
0.5 kb
TnMaxl
eat
2.32Spn
2.0
0.5
1.0 T GV,PstI
C-G
C-G
A T
G-C
G-C
G-C
\SpW
pHP4SQ \  Omega primer^
S p ç f /S tn f  GATCCCGTXXIATGACCTmGAATGACCnlEAAg^ATTATATTACrAATrAATTGCrnTTT
T4 TRANSLATION-TRANSCRIPTION
H indlll BamHI — EcoRi
ATTTTAAAAATnTTTCACAAAACGGTTrACAAGCATAAA»
TERMINATION SIGNALS
G C gG C  TCAA T CAATCACCC 
"^•CClÂGThtAG TlTpCrjCG
TG  Ç  GGATOCCCGGGAATTC 
 _______  POLYUNKER
STOP-
aphA-3 (0.65 kbp)
Smal Smai
CC(^%GTCACTAACTAGACGAAGCTAAA)ATG cat - TAA| TTTÏTTOGAOGGAATA {aTG C C C ( ^
Figure 25. Omega and aphA-3 fragments.
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original function of the gene, e.g. lose of adherence ability. The aphA-3 
cassette consists of stop codons in all three reading frames at the 5' end 
followed by a promoterless chloramphenicol resistance gene, with a down­
stream Shine Dalgamo and ATG site. Orientation of this cassette m ust be in 
frame and codirectional with the gene of interest that it is to be disrupted. It is 
designed to terminate translation of a gene in an operon yet allow translation 
of any downstream sequences on the same messenger RNA. A cartoon of 
these constructs is shown in Figure 25.
pDR4 was subcloned by H in d i  digestion and ligation into pBluescript. 
The plasmids pDR4L, pDR4.2.1 and pDR4.H.l were thus generated. A series of 
constructs were generated from these plasmids in anticipation of insertionally 
inactivating omp85 inN . gonorrhoeae by homologous recombination. Figure 
26 shows the orientation and construction of these plasmids. pDR4L contains 
a unique BszWI site into which the Omega fragment was inserted by blunt- 
end ligation. The Omega fragment used was a modification of the Omega 
fragment from pHP45Q (115). PCR amplification was used to retrieve the host 
plasmid including the transcription/ translation termination elements and 
omit the streptomycin/ spectinomydn resistance gene cassette. This was done 
because of natural resistance to streptomycin in many strains of gonorrhea. In 
its stead was placed the chloramphenicol resistance gene from TnMaxl (61). 
The promoter for this cam cassette is from one of the opa genes of gono­
coccus. The resulting plasmid was termed pHP45Co. A  Smal digest of 
pHP45CS2 results in an approximately 1000 bp blunt end fragment containing 
the cam cassette and flanking transcription/translation terminating elements. 
This fragment was inserted into the unique Bs iWl site in pDR4L which had 
been blunt-ended with Klenow fragment. The resulting plasmid was termed
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Figure 26. Omp85 mutagenesis constructs. Four plasmids were created to 
insertionally inactivate Omp85 by homologous recombination. The relative 
position of these plasmids are shown in relation to pDR4 and omp85. 
pDR4LCQ was created by inserting the Omega fragment from pHP45Cn into 
the unique BsiWI site, blunt-ended with Klenow fragment. pDR4.2.1/33 was 
assembled by inserting the aphA-3 fragment from pSL33 into the unique Nriil 
site of pDR4.2.1. pOmp85, containing the entire omp85 gene and 266 
downstream base pairs, had  the Omega fragment inserted at the unique 
BsiWl site, blunt-ended w ith  Klenow fragment. The resultant construct was 
termed pOmp85CS2. pOmp85/33 was constructed by inserting the aphA-3 
fragment into the unique N ru l  site of pOmp85.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
73
pDR4
Plac / PT3 ISad INot lEa^ IXbet ISpei IBmtiUSma /Ps«/(EcoRI)/ INSEBT/fCeofln/HWII UH nlUXM  IKpril PT7
om pSS  ORF
Hncll rtncll Hhcll OgipH B.Q
PDR4LCQ
S
Omega
Omega
pOmp85/33
I
aphA-3
PDR4.2.1/33
pOmpSSCQ
I
aphA-3
Figure 26. Mutagenesis constructs
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pDR4LCo.
The aphA-3 fragment from pSL33 (98) contains a chloramphenicol 
resistance gene but with a ribosome binding site 3' to the stop codon followed 
by an ATG codon, instead of a transcription/ translation terminator element 
as in  the Omega fragment. It also lacks a promoter, thus in-frame ligation is 
necessary. The aphA-3 fragment allows continued translation of downstream 
genes in the operon messenger RNA, should there be any polar effects of 
disrupting omp85. A  Smal fragment from pSL33 containing the aphA-3 
fragment was inserted into the N ru l site resulting in the construct termed 
pDR4.2.1/33. This Nrul site was the only convenient site in the omp85 ORF 
which would result in an in frame insertion of the aphA-3 fragm ent
Double digests of all these constructs using Sac I and X h o l  followed by 
blunt-ending with Klenow fragment was used to excise these disrupted 
ompSS  subfragments from pBluescript and place them into the unique Smal 
site of pUPI. This was done to include the gonococcal uptake sequence (DUS) 
in the construct. The DUS element is contiguous to the Smal site and is 
necessary for gonococcal transformation (46).
Finally, the Cq and aphA-3 fragments were inserted into the unique 
BsiVfl and Nrul sites of pOmp85, respectively, resulting in plasmids 
pOmp85Cn and pOmp85/33. This was done to increase the probability of 
recombination with gonococcal ompSS  by increasing the length of flanking 
DNA.
Transformations using circular and linearized pDR4LCQ, pOmp85CQ,
pOmp85/33, and pDR4.2.1/33 were attempted. pDR4.2.1/33 and pDR4LCQ 
transformants resulted m merodiploid mutants. These were termed Nru and 
Bsi, respectively. Efforts to resolve the merodiploid state into a full mutant
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were unsuccessful. Transformation using genomic DNA from these 
merodiploid mutants, continued passage on agar containing increasing 
amounts of antibiotic, and transformation using the construct digested out 
from the vector to facilitate double cross over and diminish single cross over 
events failed to resolve the merodiploid state. The former method was an 
attempt to coax the mutant gene to recombine with the wild type gene 
because of the added pressure of antibiotic in the environment, thus creating 
the need for a second copy of the gene. Because the merodiploid state could 
not be resolved to a full mutant state, that is, two copies of the disrupted gene 
and no wild type copies, it was determined that the gene is essential for 
existence in N. gonorrhoeae. Figure 27 is a western blot of the merodiploids 
showing no significant difference in Omp85 expression. Figure 28 shows PCR 
products of these merodiploids indicating the presence of both the mutant 
and wild-type Omp85 gene.
Figure 29 shows the results of gonococcal adherence to Chang 
congunctiva cells in the presense of Om p^-spedfic rabbit Fab fragments. 
Although there appears to be some non-specific adherence inhibition using 
anti-BSA and normal rabbit serum Fab fragments, clear inhibition was seen 
using Omp85-spedfic Fab, increasing in proportion to concentration. These 
results corroborate the surface location of Omp85 and support the possibility 
that the protein plays a role in adherence.
Gene Integration into the 16S rDNA Locus
Having failed to create a full Omp85 mutant in gonococci, it was of 
interest to further elucidate the function of OmpSS by placing the entire gene 
into the genome of a related bacteria which did not carry the gene. The likely 
candidate for this was B. (Moraxella) catarrhalis because of its relatedness to
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w Z
Omp85
CBB anti-OM antiserum
Figure 27. Western blot analysis of Omp85 merodiploids. Cell lysates of M Sll, 
Bsi, and Nru OmpSS transformants were separated by SDS-PAGE (12.S%) as 
shown in the left panel. Identical gel was transferred to PVDF and probed 
with anti-outer membrane antibody. OmpSS is indicated on right. Molecular 
weight markers are in thousands of Daltons (kDa).
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Figure 28. PCR analysis of OmpSS merodiploid mutants. 1% agarose gel of 
PCR products using primers as indicated. Primers S'hypoERVQ and PYFT 
produce a product of 1S94 bp in MSll and an addition^ product of 2S94 bp in 
merodiploid Bsi and an additional product of 2244 bp in Nru. This indicates 
the presense of a wüd type and mutated OmpSS allele in the merodiploid 
strains. Primers PYFT and cat3' produce a product of 221S bp in Bsi and 2189 
in Nru. This indicates that the construct had recombined with the host 
omp85 gene via a double recombination event, not in another site within the 
genome, and that pU Pl vector DNA was not included in this event. 
Molecular weight markers in kilobase pairs (kbp).
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Figure 28. Schematic view of construct recombination and PCR analysis
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Figure 29. Cell adhérence assay. Omp85-spedfic, BSA-spedfic, and normal 
rabbit sera Fab fragments were added to gonococcal MSllLosA bacteria in the 
various concentrations shown. Bacteria were then allowed to adhere to 
Chang conjunctival epithelial cells. Non-adherent cells and excess Fab 
fragments were washed off and the bacteria and host cells visualized by 
staining. Each data set represents the average number of gonococci left 
adhering per Chang cell.
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the Neisseria and the fact that it lacked omp85. Because the parameters of 
transformation and the genetics of B, (Moraxella) catarrhalis are not well 
understood at this time, a pilot project using gonococcal 16S sequences was 
attempted. A 300 base pair section of the gonococcal 16S sequence was PCR 
amplified and cloned into the pBluescript vector using prim ers rDNAStuS' 
and rDNAStu3'. A chloramphenicol resistance gene m arker was inserted into 
the Sttd  site of this segment, and the 16S construct placed into the Smal site of 
pUPl (46). Transformation and subsequent recombination with the genomic 
16S region with this construct was successful. Pursuing the feasibility of novel 
gene integration into the gonococcal genome, a construct was made using the 
luxAB  reporter gene (47) w ith the gonococcal an/A  (68) promoter. Successful 
recombination was not achieved. It was thought that the 16S portion of the 
construct was too small in comparison with the insert size and therefore a 
larger section of 16S target DNA was cloned. A 1400 bp section of the 16S 
gonococcal rDNA from strain M Sll was cloned into pUPl (46), using primers 
rDNAStuS' and 16SP3', resulting in the plasmid 1400 pU Pl. This strategy 
proved successful. Figure 30 shows the construction of pDRLuxl400.1/ pUPl. 
The Omega - a n iA -  luxAB  construct was PCR amplified out of pBluescript 
and placed into the blunt-ended AfUl site of 1400 pUFl. Following 
transformation, several recombinants were chosen and analyzed by PCR 
methods. All ten clones tested were identical; one was arbitrarily chosen and 
termed 1400.1. The PCR analysis, as seen in Figure 30, confirmed the incorpor­
ation of the construct into one of the rDNA genes. The cat gene was shown to 
be present and presumably expressing under selection conditions. PCR ampli­
fication with the 16SK5' prim er insured that the construct had indeed 
recombined with the genomic 16S site and not another random  site in the
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Figure 30. pDRLuxl400.1/pUPl plasmid construction. The aniA  promoter 
from Fanl protein (68) was synthetically constructed by first annealing 
primers aniAXSM and aniA3'.l together and filling in the complementary 
strands with Taq (Boehringer Mannheim) polymerase. Primers aniAXS' and 
aniA3', with engineered Xbal and B a mHI sites, respectively, were then added 
in a PCR reaction to amplify the entire aniA  promoter. This product was 
inserted into pBluescript at the Xbal and BaniHl sites. The luxAB genes (47) 
from pRL1062 (170) were PCR-amplified using primers HLuxS' and HLux3' 
with BamHI and Kpnl sites at each end, respectively. This product was ligated 
into pBluescript digested with the same restriction enzymes. The Co 
fragment was then ligated into the Eag I site blunt-ended with Klenow 
fragment. The resulting plasmid was termed pCX.lHlux.
The end 1436 base pairs of the 1544 bp 16S gonococcal rDNA gene (128, 
169), traversing base pairs 108 to 1544, was PCR-amplified with primers 
rDNAStu5' and 16SP3' engineered with Clal and Pstl sites, respectively. This 
product was ligated into the corresponding sites of pBluescript and called 
16S1400. The 16S1400 insert was digested out with Clal and Pstl, blunt-ended 
with Klenow fragment, and inserted into the Smal site of pUPl (46), resulting 
in the plasmid called 1400 pUPl. A unique A f i l l  site within the 16S fragment 
of 1400 pUPl was used to insert the construct of plasmid pCX.lHlux. This was 
done by PCR-amplifying out CX.lHlux using the cat5' and HLux3' primers 
and inserting this into the blunt-ended AflR  site of 1400 pUPl. The resultant 
plasmid was termed pDRluxl400.1/pUPl. All orientations were verified by 
PCR. Selection of E. coli was done on LB plates containing 50 ng/ml 
ampicillin, 30 ng/ml chloramphenicol. Selection of gonococcal recombinants 
was done on clear typing media containing 10 pug/ml chloramphenicol. 
Arrows indicate direction of translation.
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genome. This is the case because the section of 16S DNA to which this primer 
anneals is upstream from the integration site and is not in the original 
pDRLuxl400.1/pUPl construct. A map of the positions of the primers used is 
shown in Figure 31.
Figure 32 shows an SDS-PAGE analysis of MSll transformant 1400.1 
grown under aerobic, microaerophilic, and anaerobic conditions. The 54 kDa 
Pan 1 protein can be seen somewhat in the microaerophilic growth condition, 
and very strongly expressed under anaerobic conditions. Pan 1 was not 
noticeably expressed under aerobic conditions. Under all three of these 
growth conditions, ludferase activity was measured using the same am ount 
of cells with no significant difference in activity. This is shown in Figure 33. 
Thus the aniA  promoter appears to be constitutively active. A growth curve 
(Figure 34) of the parent strain M Sll compared with the transformant strain
1400.1 shows a higher growth rate for the wild type MSll, the slop of log 
phase growth being twice that of the mutant. The burden of an additional two 
genes and the absence of one or more of Ae four 16S gene lod  seems to affect 
growth of the transformant. Should more than one of the four 16S lod  
become inactivated by recombination, significant growth reduction would be 
expected. Primers upstream and downstream of each of the 16S lod would 
need to be constructed to determine precisely which and how many of the 
four 16S lod are occupied.
5. Discussion
Identification of Outer Membrane Proteins
Outer membrane proteins can be identified by several methods. An 
example of a technique not used in these experiments but one that has been 
used in gonococcal research by others is transposon mutagenesis. A genomic
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Figure 31. PCR analysis of 1400.1 and construction of 1400 pU Pl. Comparisons 
between pDRLuxl400.1/pUPl transformant 1400.1 and host gonococcal strain 
M Sll using three sets of primers as indicated. Primers arüAXS' and HLuxS' 
constitute the aniA  promoter and luxAB  gene yielding a product of 
approximately 2400 bp. Primers cat5' and Hlux3' constitute the an iA  promoter 
and luxAB  gene together with the chloramphenicol resistance gene yielding a 
product of approximately 3300 bp. Primers 16SK5' and Hlux3' constitute the 
chloramphenicol resistance gene, the aniA  promoter and luxAB  genes 
together with the upstream portion of the 16S rDNA segment yielding a 
product of approximately 3900 bp. Molecular weight markers on left in kilo 
base pairs (kbp). Adjacent is a map showing the location of various primers 
used in this analysis and in the construction of 1400 pUPl relative to the 16S 
rDNA gene.
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Figure 32. SDS-PAGE of M Sll transformant 1400.1 used in luciferase assay. 
Cells were grown either aerobically on plates, microaerophilically in broth, or 
anaerobically on plates in an anaerobe chamber. Fanl is indicated on left. 
Molecular weight standards in thousands of Daltons (kDa).
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Figure 33. Luciferase assay of gonococcal transformant 1400.1 {aniA - lux). 
Aerobically grown cells were inoculated onto clear typing media (157) for 16 
hr and then harvested. Microaerophilically grown cells used clear typing 
media without agar and 4 ml of NaHCOs (8.4%) and 2 mM NaNOz added per 
liter. Bacteria were added to an ODeoo of 0.1 and incubated at 37°C for 16 hr 
with flasks completely full of media and not shaken to prevent aeration. 
Anaerobically grown cells were inoculated onto clear typing media and a 
sterile filter disk (1.3 cm) containing 20 of a 20% NaNOz solution was place 
in the center of each plate (97). Incubation was done in a 2.5 1 GasPack 
Anaerobe chamber (BBL) containing AnaeroPacks (Mitsubishi Gas Chemical 
Co., New York, NY) at 37°C and the reducing environment monitored using 
anaerobic indicator strips (MedPak, Montvale, NJ).'CHLuxl400' is identical to
1400.1 but without the aniA  promoter. '140Œ is identical to '1400.1' excepting a 
chimeric aniA  promoter.
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Figure 34. Growth curve of M Sll and 1400.1. Cells were harvested from 16 hr 
plates and placed in 3 ml of gonococcol broth to an ODôoo of 1.0. 1 ml was 
added to 25 ml of gonococcol broth and incubated at 37°C, 225 rpm in a 500 ml 
side arm flask. Chloramphenicol was added to 10 ng/ml in the flask 
containing 1400.1.
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library is subjected to transposon mutagenesis whose inserting element 
includes a phoA gene which, when associated with a signal peptide, will yield 
a colored phenotype (75). Outer membrane proteins are usually equipped 
with a signal peptide to traverse the inner membrane to transport it to the 
outer membrane (154). Another method would be to directly search the 
genome sequence data bank against known outer membrane proteins or to 
search for know functional domains of virulence determinants.
The first approach taken in these experiments was iodination of outer 
membrane proteins. Iodination of whole cells has been an accepted method 
for identifying outer membrane proteins for many years (71, 42, 81,168, 99,
19). Because the iodagen, l,3,4,6-tetrachloro-3a,6a-diphenylglycouril, is bound 
to the reaction vessel wall where it cannot diffuse through the membrane, 
covalent binding of izsi to proteins is confined to outer membrane proteins 
(1). Fractionation of labeled cells has shown that very little contamination of 
inner membrane proteins occurs (1). In the two iodination gels, one exposed 
longer than the other, approximately 41 protein dots were identified. Some of 
these proteins yielded stronger signals than others, some disproportionate to 
their quantity. For instance, "protein 3" is barely visible in a Coomassie blue 
stained gel, yet its iodination signal is quite strong. Conversely, "protein 18", 
for example, shows significant quantity on SDS-PAGE and yet shows very 
little uptake of 12SI. This indicates chemical and/or topological differences 
between these two proteins.
Because iodine binds predominantly to tyrosine and somewhat to 
histidjne and phenylalanine (42), some outer membrane proteins could be 
missed because these residues are not exposed on the outer loops of these 
proteins. Corroborating methods, therefore, were used to establish the
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identity of these outer membrane as surface located.
Biotin labeling of outer membrane proteins is also a common 
procedure used (19,88, 1). In this system, biotin covalently binds to primary 
amines of amino add  residues of proteins; enzyme-conjugated avidin is 
added which vigorously binds to biotin, and the complex is then identified by 
adding the substrate of the enzyme. Some properties of the avidin - biotin 
system that lend themselves for use as technical tools indude high affinity 
(KD<10-i5M), multi- or monovalent binding of conjugated avidin, great 
stability, relatively small size, and  ready availability. Using this system, 
several additional proteins were identified as compared with iodine. These 
were: 2,15,16,18a, 18b, 24a, 24b, 25a, 43a, 46a, 53,54, 55, 59, 62,63, 66,67,68, 71, 
72, 73, 74, 75. The biotin capture method retrieved 8 proteins, most of which 
were dominant in the iodination method, and all of which were also seen 
with biotin labeling alone (Figure 6). This capture method could be used as a 
method to acquire large quantities of specific proteins for use in N-tenninal 
sequencing of amino adds and antibody production.
Variability between iodination and biotinylation results may be in part 
due to chemical differences in binding: iodine binds mainly to tyrosine and 
bio tin mainly to lysine residues. Because biotin is a small molecule (MW = 
556.58) diffusion through the membrane may be more of a problem (1).
Outer Membrane Fractionation and Generation of Antibody
The separation of the outer and inner membranes of the gonococcus 
has been accomplished in the past by various techniques. These indude 
solubilization with sarkosyl (118, 9), and the use of salt coupled with 
differential centrifugation (39). The purity of these fractions were less than 
optimal. This was partially due to the unusual O-acetylation of the gonococcal
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peptidoglycan which is refractory to lysozyme action. Recently, Judd, et ai,
(74) purified the gonococcal outer and inner membranes to homogeneity. 
Chemical and immunological analysis revealed a clean separation, 
demonstrating the presence of known components (e.g. cytochromes - inner 
membrane; LOS - outer membrane) of each membrane restricted to their 
respective fractions.
The purified gonococcal outer membrane was iiqected into rabbits to 
produce polyclonal antibody specific to outer membrane components. Figure 
4 shows 47 gonococcal proteins recognized by this antibody. Western blotting 
of two dimensional gels details many proteins common w ith iodination of 
the same proteins. This same result was obtained by others with Yersinia, 
comparing western blots using antibodies generated to whole cells and 
iodination (95,144). Specifically, proteins 3,4, 6, 7, 9 ,11 ,12 ,13 ,17 ,17a, 18, 20,
25, 26, 26a, 31,34,39, 46, 56 were found to be common between the two 
labeling techniques.
Differences seen between the two techniques may be explained by 
noting that the antibody was generated to outer membrane fraction of . 
vigorously growing log phase cells. These proteins may vary quantitatively 
and qualitatively from gonococci grown on 16 hr plates. It should also be 
noted that neither of these growth conditions may reflect the protein profile 
of gonococci resident in a hum an host. Thus, some outer membrane proteins 
may not be identified by antibody or iodination (e.g. Panl [68]). In addition, 
the enzymatic and sonication method of extraction used in the fractionation 
technique used in the preparation of the outer membrane antisera could 
generate epitopes not included on the reducing conditions of two dimen­
sional gel electrophoresis. For this reason, some proteins may not be labeled
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or others labeled that should not be. Also, isoelectric focusing can yield slight 
variations in protein dot coordinates from gel to gel and thus some proteins 
may be misidentified, especially those in the 44 kDa region where there is a 
high density of protein types. These differences may explain some of the 
variation seen between these two systems of labeling.
Seventeen proteins were found to be common to all three labeling 
techniques as shown in Figure 8.
Isolation of Specific Proteins
Once proteins were identified as being outer membrane in origin, the 
first approach taken in these experiments to isolate and characterize the 
protein was by direct N-terminal sequencing. The amino ad d  sequence of the 
protein would then lead to function by homology to other known outer 
membrane proteins. Several attempts were made using either whole proteins 
or fragments of proteins without success. Direct N-terminal sequencing has 
many problems assodated with it, induding sensitivity to oxidation and 
terminal blockage, and the necessity for relatively large amounts of material 
(32). Due to these limitations this approach was dropped.
The anti-outer membrane antibody was used to screen a genomic FA19 
library. Sixteen proteins were identified from homology searches (3) using the 
partial DNA sequence of the inserts. Only one done, pDR3.3, did not 
hybridize with any known protein in the DNA data bank. Several of these 
proteins seemed to be involved in general 'housekeeping' type functions (e.g. 
inosine-5'-monophosphate dehydrogenase, dihydrolipoamide dehydrogen­
ase) while others piqued interest as possible virulence determinants: 
pDR22.E.l - Listeria invasin protein, pDR3.7 - leukotoxin. By no means do 
these 16 proteins represent the enfire complement of outer membrane
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proteins. There was no indication that the library was exhausted  of further 
unique clones. Many positive archived clones were never sequenced.
Omp85
The protein of in terest to o u r lab was the analog of the Haemophilus 
in flu en za e  D15 protective surface antigen (71,161,166, 89, 166). Antisera to 
D15 antigen was show n to be protective m  an  infant rat m odel study  against 
liv e  H. influenzae challenge (49). In addition, hum an convalescent sera from 
patients w ith epiglottitis o r m eningitis were reactive to D15, and  antigenicity 
in  typeable and  nontypeable H. influenzae strains appears to be universal (91).
There are no good anim al m odels for N. gonorrhoeae infection, thus 
testing the hypothesis that antibodies to Omp85 w ould be protective against 
challenge, as was w ith H. influenzae  in rat pups, is no t possible. H um an 
convalescent sera from  patien ts w ith  DGI and m eningococcem ia w ere shown 
by w estern blotting to be reactive. These results dem onstrate  tha t Omp85 is 
expressed in vivo  and  th a t the p ro tein  is antigenic in  hum ans. The antigenic 
universality seen in  H. influenzae  w as also observed in  N. gonorrhoeae. AU 
strains tested contained the Om p85 gene and expressed the protein. Omp85 
was also shown to be expressed in  aU Neisserial com m ensals tested, sugges­
ting that is necessary for establishing and m aintaining m ucosal infection. 
These characteristics, in vivo  expression, antigenicity, an d  universal expres­
sion, are prim ary considerations in  subunit vaccine developm ent. Since 
antibodies to Omp85 analogs in  H. influenzae and  P. multocida w ere protec­
tive against chaUenge, it m ay be true  that antibody to gonococcal Omp85 
generated in hum ans d u rin g  infection may contribute to the elim ination of 
the bacteria by the im m une system.
The gonococcal D N A  sequence of the region su rround ing  Omp85 is
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know n (41). These genes are involved  w ith  lipid A biosynthesis. These same 
genes are found in several of the pathogenic organism s discussed as contain­
ing analogs of Omp85. The linkage of these is given here:
Omp85 IpxA - fabZ - IpxD - hlpA - Omp85 - hypothetical protein - cdsA
Omp85M C (150) IpxA - fabZ - IpxD  Omp85
P. multocida (36) firA - skp - Oma87
H. influenzae D15 {50) firA- s k p-  D15- hypothetical protein - cdsA
£. coli (17) IpxA - fabZ - IpxD - hlpA - Omp85 - yeaL
B. abortus (10) IpxA - fabZ - IpxD  Ompl - hypo. - hypo. - cdsA
[Protein h ip  A is also know n as skp o r O m pH ; protein IpxD has also been 
term ed firA. Dotted sections indicate that the intervening sequences a t the 
juncture  a re  not known.]
W ith the exception of yaeL  (E. coli) and  om p85, all these gene functions are 
know n an d  have been characterized as being involved in lipid m em brane 
synthesis. W hether Omp85 is also involved in lipid synthesis can  only be 
hypothesized by association w ith  these genes. In gonococci, the intergenic 
spaces betw een each of these genes are less than 100 bp, perhaps suggesting 
that it is p a rt of an operon. The idea of an  operon is also suggested by the 
apparen t lack ot a o m p S S  prom oter. Schnaitm an (135) has suggested  tha t these 
genes are in  a so-called 'm acrom olecular II operon". Briefly, the p roposed  
operon  consists of: IpxA  gene, w hose p roduct catalyzes the first step  in  lipid A 
biosynthesis (4); polC (dnaE) w hich encodes the a  core subunit of D N A  poly­
m erase ni; the m h  gene encoding RNaseH; the IpxB an d  IpxD  genes w hich 
also function in the lipid A biosynthetic pathw ay (136); the cdsA  gene w hich 
encodes CDP-diglyceride synthetase, an  essential step in  biosynthesis of
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glycerophospholipids (136); and  the om pH  gene (also referred  to as skp or 
h ip  A) gene which encodes a 16 kDa protein active in  fo ld ing  pro tein  in the 
periplasm  (101).
Argum ent against an  operon  can be m ade by no ting  th a t the genes 
involved in m em brane phospho lip ids synthesis in E. coli are  scattered 
throughout the genom e ye t are  coordinately transcribed (116). In  addition, 
rho-independent term inators w ere found im m ediately u p stream  and  down­
stream  of Omp85, suggesting  independent regulation.
A search of the O m p85 am ino add  sequence against the  GenBank data 
base also revealed a hom ology w ith  a cyanobacterium  p ro te in  (75a). The 
cyanobacterium protein w as nam ed IAP75 because of its sim ilarity  to the 75 
kD chloroplast im port a sso d a ted  protein, IAP75 (139). T he chloroplast 1AP75 
was located in  the ou ter m em brane of chloroplasts and  w as one of four com­
ponents of a polypeptide tran spo rt complex. This suggests tha t Omp85 might 
be p a rt of a similar transport complex.
The sequences of o th e r proteins from the chloroplast im port assodated 
complex were searched against the gonococcal genom e sequence data  base 
(41). A gonococcal p ro tein  sim ilar to a purported G TP-binding protein, IAP34 
(78a), was identified. The areas of highest hom ology w ere  in  the regions 
identified as GTP-binding p ro te in  motifs. Surface-crosslinkage studies by Dr. 
R alph Judd w ere perform ed to determ ine if Omp85 m igh t p a rtid p a te  in a 
system  analogous to the lA P complex. Studies using the crosslinker DTBP 
(104a) showed that Omp85 w as w ithin  11.9Â of up  to five pro teins, one of 
=34 kDa, possibly being a IAP34 homolog. These data  su p p o rt the possibility 
that Omp85 m ight p a rtid p a te  in  a complex analogous w ith  the  chloroplast 
lAP complex.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
98
In sum m ary, Omp85 m ay be involved in the m em brane lipid A 
biosynthetic machinery, or in  a polypeptide transport com plex located on the 
ou ter membrane. Its surface location is evidenced by iodination, 
biotinylation, anti-outer m em brane antibody adherence, the  presence of a 
signal peptide, and hom ology to several other know n Omp85-like outer 
m em brane proteins.
Omp85 M utants
Attem pts at insertional inactivation of Omp85 by hom ologous recom­
bination resulted in a state of m erodiploidy, a com m on occurrence in gono­
coccal recombination (personal com m unication W. Shaffer). This is probably 
due to the dual chrom osom e na tu re  of diplococd: one chrom osom e contain­
ing the m utated  version to surv ive  on selective m edia, the  o ther maintain­
ing the wild type. A ttem pts a t resolving the m erodiploid to a complete
m utan t were not successful. Because E. coli DH5a  and B.(Moraxella)
catarrhalis seem to survive w ithou t the gene, it is tem pting to speculate the 
non-essential nature of Om p85. The aphA-3 m utant, N ru, theoretically 
insures transcription of dow nstream  elements w ithin a possible operon; thus 
if an  operon is involved w ith  Om p85 production, the o ther com ponents of 
that operon w ould not be afiected. This does not abrogate the  necessity of any 
essential genes, however. It is possible that Omp85 in gonorrhea has addition­
al functions no t found in E. coli DHBa. or B. (Moraxella) catarrhalis, thus 
m aking its existence essential.
The condusion of the m utagenesis studies is that O m p85 is essential to 
gonococcus. It is interesting to  note in Figure 26 that w ild type Omp85 levels 
of expression is similar to levels in  the m erodiploid m utants, suggesting 
som e com pensatory transcrip tion  or translation action to m ain tain  the same
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pro tein  concentrations. T hus there  seems to be som e varia tion  in the am ount 
of Omp85 able to express in  the  gonococcal genome.
Cell Adherence
Because there was som e inhibition of adherence of gonococcal cells to 
Chang conjunctiva cells using  non-specific Fab fragm ents, it could be 
in terpreted that the Fab fragm ents cause a steric h indrance to adherence. The 
decrease of adherence to gonococci to Chang cells w ith  anti-Om p85 Fab could 
be sim ply a dosage effect: since there are presum ably  num erically m ore 
Omp85 molecules, and  therefore  antibody b inding sites, in  the outer 
m em brae that there are ran d o m  sites to w hich anti-BSA o r norm al rabbit 
serum  Fab binds, that there w as a com m ensurate decrease in adherence due 
to steric hindrance. Should Om p85 be involved in  p ep tid e  transport or 
m em brane synthesis as hypothesized , antibody adherence, under described 
experim ental conditions, m ay in terfere w ith Om p85 function. It w ould seem 
unlikely that aberation of function  of this type m olecule w ould  directly cause 
a decrease in adherence.
It is possible that O m p85 is indeed directly involved w ith  adherence 
via a eukaryotic receptor. Based on know n com ponents of the outer 
m em brane of gonococci invo lved  w ith  this read to n , it appears that several, 
not just one or two com ponents, are necessary. Therefore, if Omp85 has 
evolved to play a role in these actions, it w ould  be only one com ponent of 
m any whose additive effect prom otes adherence.
Gene Integration
Omp85 expression w as observed in all Neisserial sp ed es tested. One 
m ethod of discerning gene function  is to knock ou t the gene and  note 
phenotypic changes in the m u ta n t as com pared to the w ild type. Since this
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was not possible, an alternative is to find a strain that d id  not carry the gene 
and observe any phenotypic changes as com pared to those strains which did. 
This also w as not possible. B. (Moraxella) catarrhalis is closely related to the 
genus Neisseria genetically (127) and  is also a m ucosal pathogen. It was 
hypothesized that om p85 could  be introduced into B. (Moraxella) catarrhalis 
by insertion into one of the 16S rD N A  sequences in the genom e by hom olo­
gous recom bination w ith  a construct containing the 16S rD N A  w ith  omp85 
inserted w ith in  it. A pilo t project w as attem pted using 16S sequences from 
bo th  N. gonorrhoeae and  B. (Moraxella) catarrhalis w ith  a chloram phenicol 
resistance gene m arker in serted  w ith in  the ORF. T ransform ation of these 
constructs in to  their respective hosts resulted in  recom bination only in  N. 
gonorr/iocfle. Reasons for failure in B. (Moraxella) catarrhalis coxûd he 
several: one, B. (Moraxella) catarrhalis does not recognize the cat prom oter 
u sed  (gonococcal O pa prom oter(61)); two, transform ation was never achieved: 
no one has transform ed B. (Moraxella) catarrhalis-with anything bu t 
chrom osom al DNA from  o th er B. (Moraxella) catarrhalis strains using the 
pilus adherence technique (28). There could also be a m éthylation problem  
resulting in  total restriction of the E. coli -derived p lasm id  DNA. Transfor­
m ation was also a ttem pted  by electroporation (63) w ith ou t success; or thirdly, 
though no t likely, there is only one 16S rDNA loci and in terrup tion  of this 
gene w ould be lethal. Should B. (Moraxella) catarrhalis be  used in the future 
perhaps d ifferent strains m igh t w ork  better.
As a p ilo t experim ent for in troducing novel genes into the genom e of 
gonococcus or related species, a  project was begun to insert a  reporter gene 
regulated w ith  a gonococcal p rom oter into the genom e of gonorrhea by 
hom ologous recom bination w ith  the 16S rDNA. The p rom oter chosen w as
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a n i A  from Pan 1 (69). Pan 1 is an inducible nitrite reductase (97) that is tran­
scriptionally unregulated under anaerobic conditions. Anaerobiosis alters the 
expression of at least seven o ther gonococcal outer m em brane proteins (97). 
H um an  convalescent serum  reacts w ith  Pan 1 suggesting anaerobiosis is a 
norm al m ode of m etabolism  for the gonococcus in hum ans. The term inal 
electron acceptor supporting g row th  in  vivo appears to be n itrite  (80). N itrite 
is p resen t in  biological fluids, including urine, blood and  saliva (80), and 
a lthough gonococci cannot reduce n itrate  to nitrite, o ther bacterial species 
w hich  are norm al flora in  these sites can reduce nitrate to nitrite. W hen 
gonococci are grown anaerobically, a n i A  is transcribed and Pan 1 is produced 
(Figure 31).
T he aniA  prom oter is complex, containing o70 and  E. coli "G earbox"
consensus sites (68). Its expression m ay involve the presence of a  repressor 
p ro tein  (68) similar to those genes in  E. coli upregulated u n d e r anaerobic 
conditions. The full sequence of the a n iA  upstream  region has not been 
published and  the sequences of Pan 2 and Pan 3 proteins, also upregulated  
u n d e r anaerobic conditions in gonococci, are not known. The gonococcal 
sequencing project is no t yet com plete and  searches using the a n iA  prom oter 
as a  probe d id  not find any hom ologous regions. Thus it m ay be that the 
sequences are not in the data  bank o r  the prom oters of Pan 2 and  3 are 
sufficiently difrerent so as not to hybridize with the a n iA  prom oter. W hat was 
used  was the upstream  159 base pairs w hich included the gearbox prom oter 
elem ent bu t no t the o70 elem ent, o r  any elements upstream  of that. The 
original stra in  used for this sequence w as RIO (68). This particu lar strain  was 
no t available b u t a related strain, F62, w hich Hoehn and  C lark used for other
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Pan 1 work, was available. A fter synthesis of prim ers based o n  the published 
sequence of the a n / A prom oter (68), a  PCR amplification p ro d u c t was cloned 
and  sequenced. The approxim ately  100 bp fragm ent proved to  be chimeric, 
having the correct 5' and  3 '-end  sequences but the incorrect in ternal se­
quences, presum ably found  only in  strain RIO. Figure 28 show s the form at of 
constructed internal prim ers to obtain  the correct sequence fo r the a n iA  
prom oter. As a negative control, the incorrect prom oter w as also used to 
assemble the 16S reporter construct. It was term ed pD R L uxl400/pU Pl. The 
M S ll transform ant w as term ed  sim ply 1400. In addition, a n  identical con­
struct, CHLux, w as created w ithout the an iA  prom oter entirely.
The reporter gene chosen w as the Vibrio harveyi lud ferase  gene, lux 
(GenBank accession # X58791, 47). The luxA B  gene is derived  from  a six 
m em ber operon. The lud ferase  enzym e, coded by lux  A  and  luxB , catalyzes 
the following reaction: FM NHz + RCHO + 0 2 =  FMN + RCOOH + H iO  + 
light, in which R is a s tra igh t chain aldehyde of seven or m ore carbon atoms, 
FMN is flavin m ononucleotide, and  FMNHz is reduced flav in  m ononucleo­
tide. The production of light from  bacterial ludferase can be detected  w ith a 
photom eter. A linear relationship  exists between the am oun t of light 
p roduced to the am ount of enzym e present. Bacteria w hich contain  ludferase 
b u t no substrate (aldehyde) are phenotypically dark. Such cells can be m ade to 
emit light by the external add ition  of substrate to the grow th  m edia (25).
There are m any reasons w hy bacterial ludferase is an  excellent reporter 
gene. Comparing it w ith  ano ther comm on reporter gene, B galactosidase, IQi i 
molecules are needed to generate a measurable signal (50 U o f enzyme;
A 4 2 0  = 0.1); in contrast, 105 m olecules of ludferase emits 2.7 X ICK quanta of 
light which yields about 2,500 cpm  in a scintillation counter w ith  the coind-
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dence tu rned  off. This is a difference in  m agn itude  of 5 to 6 orders (25). The 
low er lim it of light detection of ludferase  is 100 molecules (62). The half life 
of V. harveyi ludferase is approxim ately 2 hrs. This is convenient for reacti­
va tion  an d  regeneration of the pro tein  for real time experiments, as opposed  
to enzym atic assays which are generally one  tim e use only. A lthough oxygen 
is needed  for the reaction, vanishingly sm all quantities are necessary. The 
threshold  of oxygen requirem ent is 0.1 nM . The norm al oxygen tension 
w ith in  eukaryotic cells in culture is 1 nM  (33). Ludferase has been expressed 
in  the  anaerobe Clostridium perfringens (113), thus oxygen presence is of no 
practical concern. Ludferase has been used  for the detection of gene expres­
sion (107, 112) as well as following infection in  living hosts (33). A nd finally, 
the a ldehyde substrate is readily absorbed th ro u g h  the cell m em brane of bo th  
eukaryotic and procaryotic organism s w ith  no apparen t consequences (170), 
w hereas the substrate for B-galactosidase is toxic to gonorrhea (143).
The a n iA -lu x  transform ant, 1400.1, em itted  light, upon addition  of 
substrate, under aerobic, m icroaerophilic, a n d  anaerobic conditions, w hile the 
negative control group did not. Since the p rom oter was active in  aerobic an d  
anaerobic conditions, it appeared that the en tire  aniA  upstream  sequences 
were not present to yield p roper anaerob ic/aerobic  control. A three h u n d red  
base pa ir upstream  sequence w as successfully used  in  a similar experim ent 
using B- galactosidase as the reporter system  in gonorrhea (143), but, these 
sequences were not available. A pparently  the  'gearbox' portion of the a n iA  
p rom oter is suffident for constitutive expression. The construct d id  success­
fully in tegrate into the 16S region, as verified  by PCR analysis (Figure 29). 
There w as no background transcription of the prom oter-less lu x  gene by 
virtue of its placem ent in the 16S rDNA region, as evidenced by no light
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em ission from the prom oterless CH Lux construct.
The grow th curve com parison betw een  w ild type M S ll and  the a n iA -  
lu x  transform ant, 1400.1, show s a decrease in  grow th in 1400.1. The inactiva­
tion of m ore than one of the 16S rD N A  sequences could be the cause. PCR 
prim ers specific to each 16S loci w ou ld  answ er the question of w hich and  how  
m any sites are occupied. A g row th  ra te  com parison betw een 1400.1 an d  a 
transform ant whose identical 16S rD N A  locus w as inactivated w ith  a cam 
cassette only would also help answ er the question  w hether the LuxAB pro­
teins are a t all toxic to gonorrhea, an d  therefore causing a decrease in  grow th  
rate.
Possible applications for use of 1400.1 could be to follow the course of 
infection in  real time in  cell cu lture an d  organ  explant assays, or following 
ingestion in  phagocytosis. Further m anipulation  could easily be obtained by 
replacem ent of the p resen t p rom oter w ith  the full functional aniA  p rom oter 
once the sequence is published, o r any o ther functional prom oter.
Considering the general use of a recom bination system  using the 16S 
rD N A  target for in tegration of novel genes into the genome of Neisseria 
gonorrhoeae, two caveats need to be  addressed. Because there are four 16S 
rD N A  lo d  in  the gonococcal genom e (169), and  presum ably only one o f the 
four is involved w ith a  recom bination event for any given transform ant, 
each locus may have its ow n unique genetic characteristics based on  its 
respective genetic environm ents. It is possible that local D N A -dependent 
RNA polymerase activity m ay be d ifferent for each lod, m aking background 
transcription a problem. Each transform ant should  be assayed for this 
possibility. The other consideration is that of titration of prom oter activity.
Any prom oter used w hose coun terpart is still in tact in the genom e w ould
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cause a diluting effect on  activity w ith  the native prom oter. This w ould not 
be a problem w ith  novel p rom oter elements or where the ho st genom ic copy 
of the prom oter is completely inactivated.
The 1400 pU Pl vector is now  poised to be a vehicle of transform ation 
an d  recom bination in N. gonorrhoeae. Any suitable construct could be 
inserted  into the A fM  site w ith in  the 16S region. A n engineered  m ultiple 
cloning site could also be constructed into this site, allowing for convenient 
insertions. A unique BgUL site on  the pU P l vector makes a convenient cut 
site for linearization, a schem e w hich often adds great efficiency to transfor­
m ation in the gonococcus (54). The 1400 base pair 16S construct w as chosen 
over the original 300 base pa ir 16S fragm ent because of efficiency of recombin­
ation: aU transformants had  in tegrated  into a 16S region w ith  the 1400 base 
pa ir version, whereas w ith  the 300 bp  constructs only a small fraction of 
transform ants actually in tegrated  into the 16S site. The rem ainder apparently 
integrated elsewhere in  the genom e.
6. Sum m ary
A gonococcal expression library was screened with an tibody against an 
o u te r membrane fraction. Sixteen unique proteins w ere identified . Among 
them  was an 85,000 Dalton p ro te in  (Omp85) that was hom ologous to similar 
proteins in six other bacterial pathogens. Antibodies to the O m p85 analogs in 
two of these species, Haemophilus influenzae and Pasteurella multocida, 
w ere protective to live challenge in  anim al models. Omp85 p ro te in  was 
constitutively and  universally expressed in all gonococcal a n d  meningococcal 
strains tested. The genes encoding the Omp85 proteins from  N. gonorrhoeae 
and  N. meningitidis w ere cloned and  sequenced. Insertional inactivation of 
the gene in N. gonorrhoeae resu lted  in a m erodiploid state, suggesting the
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essential nature of the gene.
A m ethod of gene in troduction  into the genome of N. gonorrhoeae 
w as developed using the 16S rD N A  locus as an  integration site. A construct 
using the gonococcal prom oter, a n iA ,  and  the bacterial ludferase gene, lu xA B , 
w as created to assay potential function  of the integrated gene. The transfor­
m ant, 1400.1, was isolated and assayed  for ludferase  activity. Expression was 
constitutive under aerobic and  anaerobic  conditions. An integration vector, 
1400 p U P l, has been constructed fo r fu rther m anipulations of this kind in  N. 
gonorrhoeae.
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